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ABSTRACT 
 
Jean Marie Davidson:  S PHASE-COUPLED E2F1 DESTRUCTION ENSURES 
HOMEOSTASIS IN DEVELOPING TISSUES 
(Under the direction of Robert J. Duronio) 
 
 
A fundamental question in biology seeks to understand the balance acheieved by 
rapid proliferation and careful regulation of genomic integrity that is essential for generating 
and maintaining complex multi-cellular organisms.  Cells require the ability to divide 
incredibly quickly, especially during early development, to achieve the appropriate size in a 
short amount of time.  However, rapid proliferation is dangerous.  Defects may arise when 
cells duplicate rapidly and if these defective cells are not recognized there may be serious 
consequences for the health of the organism.  Therefore the cell has in place many 
checkpoints and strategies to balance proliferation with careful regulation.  Here we present a 
novel mechanism to address this issue.  The transcription factor E2f1 is a potent activator of 
cell cycle progression and critical for normal G1-S transitions.  It is carefully regulated prior 
to the transition by Rbf1 and many upstream effectors.  Recently, the mechanism of its 
destruction during S phase has been described.  We describe the consequences of blocking 
this normal destruction.  Surprisingly, the programmed cell death that arises from 
stabilization of E2f1 is not solely due to it’s transcriptional activity, but instead relies on an 
elegant mechanism to “sense” inappropriate E2f1 levels to activate apoptosis before any 
potential defects of hyper-proliferation may occur.  Therefore E2f1 acts both to drive 
proliferation and tissue growth, but also as a reporter molecule for defects in normal cell 
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cycle progression which can  result in the clearing of that damaged cell to maintain tissue 
homeostasis.  We propose that this mechanism is in place in order to balance the rapid 
proliferation required for normal development with the fundamental requirement of genomic 
integrity. 
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INTRODUCTION 
 
Establishing and maintaining proper patterning, timing, and tissue organization are 
critical for normal development.  This process requires precise control of cell proliferation 
and cell death.  These seemingly opposing influences must be balanced in order to achieve 
homeostasis.  Inappropriate activation, or repression, of either can have severely detrimental 
consequences.  Loss of proliferation is associated with senescence and some early aging 
disorders such as progeria, whereas hyper-proliferation is a classical hallmark of 
tumorgenesis and cancer (Burtner and Kennedy, 2010; Hanahan and Weinberg, 2011).  A 
host of complicated decisions must occur to transition from a single cell after fertilization 
into a complex, multi-cellular, organism.  The proliferation of cells in a tissue is regulated by 
various intrinsic and extrinsic cues.  In multicellular organisms, the cell cycle is usually rapid 
during early embryogenesis, resulting in a sufficient number of cells for tissue formation. 
Later in development, it becomes important to arrest the cell cycle before cells differentiate.  
Specific adult cell populations must maintain the ability to re-enter the cell cycle upon 
mitogenic signaling, especially rapidly proliferating epithelial tissues such as skin, lung, and 
intestine.  In contrast, other cells must exit the cell cycle definitively and their proliferation 
could have severe consequences (Hanahan and Weinberg, 2011). The failure to arrest the cell 
cycle when required may cause neoplastic growth and eventual cancer development.  
Another mechanism of ensuring tissue homeostasis is programmed cell death, or apoptosis 
(Fuchs and Steller, 2011).  Cells that can no longer contribute to the health of the organism 
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are specifically culled before they can harm the surrounding tissue, or ignore regulatory cues.  
There is also a requirement for apoptosis during normal development, as rapid morphological 
changes occur that require the loss of specific cell populations.  Again, mis-regulation of this 
powerful molecular mechanism has potentially serious consequences during development 
and the adult life of the organism. Therefore, it is critical to understand the mechanisms at 
work to balance the proliferation, arrest, and the critical role of programmed cell death during 
development to understand how homeostasis is maintained, and how disruptions of these 
mechanisms may act as initiating events in disease.   
 
The regulation of the G1-to-S transition 
The canonical cell cycle is made of four phase: G1, S, G2, and M. During S phase, 
DNA synthesis takes place and the whole genome is replicated, resulting in two identical sets 
of genomes in one nucleus. During M phase, the replicated genomes are divided into two 
nuclei, and the subsequent cytoplasmic division results in two daughter cells. G1 and G2 
phases are defined as gap phases that separate S phase and M phase. In these gap phases, 
proteins required for the subsequent phase are actively synthesized.  There are many factors 
that regulate this canonical cell cycle, most of which tend to function at the major transitions 
including the G1 to S transition and the G2 to M transition.  Some of these factors include 
transcription factors and Cyclin/Cyclin dependent kinase complexes (Cyc/Cdk).  Cyc/CDK 
complexes phosphorylate a plethora of proteins, and this phosphorylation coordinately drives 
these transitions into a new cell cycle phase.  Cyclins are destroyed each cell cycle, and 
because of this every cell cycle transition requires the new synthesis of Cyclins, which is 
achieved by the activity of a variety of transcription factors. One such transcription factor is 
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E2F, which, together with its heterodimeric partner DP, induces transcription of genes 
involved in DNA synthesis, mitosis, apoptosis, DNA repair, and differentiation at the G1-S 
transition (Blais and Dynlacht, 2004; Iaquinta and Lees, 2007; Lee and Orr-Weaver, 2003; 
Stevaux and Dyson, 2002). E2F is negatively regulated by pocket protein family members 
including the retinoblastoma tumor suppressor protein (pRB), p107, and p130. To add further 
complexity, pocket proteins are negatively regulated by Cyc/CDK-mediated phosphorylation.   
 
Figure 1.1: Roles and Regulations of Drosophila E2f1. The E2F transcription factor, together with its 
heterodimeric partner DP, induces DNA replication genes such as, ribonuclease reductase small subunit (RnrS), 
proliferating cell nuclear antigen (Pcna), and DNA polymerase. Because of this, E2f1 acts as a strong positive 
regulator of the G1-to-S transition. E2f1 is negatively regulated by pocket protein family members (represented 
by Rb in this figure). The phosphorylation of pocket proteins by Cyc/CDK complexes results in the dissociation 
of pocket proteins from E2F, allowing the induction of E2f1-target gene transcription 
 
Once the activities of E2F and CycE/CDK2 reach a critical threshold, they 
synergistically activate one another, facilitating the robust entry into S phase. However, the 
activities of E2F and CycE/CDK2 must be suppressed both when the cell is in a quiescent 
state (G0 phase), and when DNA replication is initiated (S phase). Indeed, Cyc/CDK is 
negatively regulated by CDK inhibitors such as p16INK4a and p27Kip1 (Sherr and Roberts, 
1999), and by the proteasome-mediated destruction of Cyclins (Nakayama and Nakayama, 
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2006). The negative regulation of Cyc/CDK occurs in a timely manner during the cell cycle, 
and the misregulation of these mechanisms often results in ectopic S phase (Chen and Segil, 
1999; de Nooij et al., 1996; Lane et al., 1996; Lowenheim et al., 1999; Moberg et al., 2001). 
In addition to Cyc/CDK regulation, previous studies have identified mechanisms that 
negatively regulate E2F activity. The negative regulation involves pocket proteins, repressor 
E2Fs, proteasome-mediated destruction, CycA/CDK2-mediated phosphorylation, and 
transcriptional repression. 
 
The regulatory mechanisms of mammalian and Drosophila E2Fs  
In mammals, eight E2F genes have been identified, and can be generally categorized 
into two groups: activator E2Fs (1, 2 and 3a) and repressor E2Fs (3b and 4-8). When 
activator E2Fs are overexpressed in cultured cells, they often induce S phase entry, followed 
by apoptosis (Kowalik et al., 1995; Qin et al., 1994; Shan and Lee, 1994; Wu and Levine, 
1994). Conversely, the triple knockout of E2f1-3 in mouse embryonic fibroblasts completely 
arrests the cells cycle (Wu et al., 2001). 
As mentioned above, the activity of these activator E2Fs must be suppressed when 
the cell has initiated DNA replication (S phase). Failure to suppress E2F activity in S phase 
may cause ectopic S phase re-entry or re-replication. Indeed, a significant number of studies 
in mammals have revealed several mechanisms that suppress activator E2Fs.   First, activator 
E2Fs are repressed in G0/G1 by the binding of pRB to the C-termini of E2Fs. This binding 
interferes with the transcriptional activity of E2Fs. In addition, E2F-bound pRB recruits 
various chromatin regulatory complexes that contribute to the repression of transcription 
(Blais and Dynlacht, 2007; Frolov and Dyson, 2004). A widely-accepted mechanism to re-
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activate pRB-repressed E2Fs is that extracellular signals induce the transcription of CycD, 
which binds to and activates CDK4 and 6. CycD/CDK4 and CycD/CDK6 then 
hyperphosphorylate pRB, which leads to the dissociation of pRB from E2F (Frolov and 
Dyson, 2004). The importance of the pRB-mediated repression is inferred by the fact that 
many types of cancers have mutations in the Rb gene, and that the loss of Rb in model 
animals leads to failure to maintain cell cycle arrest (Jacks et al., 1992; MacPherson et al., 
2003; Ruiz et al., 2004; Wu et al., 2003). Also, reduction of E2F activity can suppress tumor 
formation due to loss of pRB (Lee et al., 2002; Yamasaki et al., 1998; Ziebold et al., 2003).  
Upon entry in to S phase, there are specific mechanisms to disrupt E2F activity.  The 
first mechanism involves the phosphorylation of DP by CycA/CDK2 in S phase. DP forms 
heterodimers with E2Fs, and this heterodimerization is required for the binding of E2F/DP to 
DNA. In S phase, CycA/CDK2 binds to the N-terminus of activator E2Fs and phosphorylates 
E2F-bound DP, leading to the dissociation of E2F/DP from the DNA (Dynlacht et al., 1994; 
Dynlacht et al., 1997; Krek et al., 1994; Krek et al., 1995). It is predicted that this free dimer 
is then targeted for destruction via the ubiquitin-proteosome pathway during S phase.  In 
mammals, the Cul1SKP2 ubiquitin ligase complex has been linked to the degradation of E2F1. 
Cul1SKP2 binds to the N-terminus of E2F1, leading to the ubiquitination and subsequent 
destruction of E2F1 (Marti et al., 1999). Other studies showed that the C-terminal truncation 
of E2F1, 2 and 4 stabilized these proteins, and E2F1 was protected from ubiquitination and 
destruction when bound by pRB (Campanero and Flemington, 1997; Hateboer et al., 1996; 
Hofmann et al., 1996). As a final means of protecting against inappropriate E2F activity, 
activator E2Fs on gene promoters are replaced by repressor E2Fs during G0/G1, which 
results in the suppression of E2F-responsive promoters (Trimarchi and Lees, 2002). Recent 
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reports have showed that homo- and heterodimers formed by mouse E2F7/8 bind to the 
promoter of the E2f1 gene and repress the transcription of E2f1 in S/G2 (Li et al., 2008). The 
combinational loss of E2f7 and 8 resulted in embryonic lethality with massive apoptosis 
induction, and the apoptosis was suppressed by additional deletion of E2f1, suggesting that 
the negative regulation of E2F1 by E2F7/8 is important for animal development. 
It becomes evident, based on the multiple mechanisms in place to ensure E2F 
activity is down-regulated upon S phase entry, that there must be critical consequences of 
inappropriate activator E2F function. However, the redundancy that exists in mammals 
among the eight E2Fs, two DPs (DP1 and 2), and three pocket proteins (pRB, p107, and 
p130) makes it difficult to directly address this question. A more simplified E2F/DP/RB 
pathway has been characterized in Drosophila melanogaster, providing an excellent model 
system to investigate the regulatory mechanisms of E2Fs. In Drosophila, two E2Fs (E2f1 and 
E2f2), one DP, and two pocket proteins (RBf1 and Rbf2) have been identified (Lee and Orr-
Weaver, 2003). E2f1, the only known activator E2F in Drosophila, shares major 
characteristics with mammalian activator E2Fs. It induces transcription of genes involved in 
DNA synthesis such as Cyclin E, RnrS, Pcna, and DNA polymerase alpha (Dimova et al., 
2003; Duronio and O'Farrell, 1994).  Mutation of E2f1 is lethal and causes inhibition of S 
phase during embryogenesis (Duronio et al., 1995), and overexpression of Drosophila E2F1 
can induce ectopic S phase entry and apoptosis (Asano et al., 1996; Du et al., 1996b; Duronio 
et al., 1996), supporting the idea that Drosophila E2f1 is a positive regulator of the G1-to-S 
transition. Furthermore, the mechanisms to suppress activator E2Fs are conserved between 
mammals and Drosophila to some extent. Like mammalian activator E2Fs, Drosophila E2f1 
is repressed via RBF1-binding (Du et al., 1996a; Xin et al., 2002), and E2f2 has been shown 
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to suppress the transcription of E2f1-target genes (Frolov et al., 2001; Weng et al., 2003).  
However, other aspects of E2f1 biology were not conserved, namely the down-regulation 
upon S phase.   Unlike mammalian activator E2Fs, no known Cyclin-binding site has been 
found in Drosophila E2f1.  Previous work has suggested a ubiquitin-mediated proteolysis of 
Drosophila E2f1 dependent on the Cul1Slmb ubiquitin ligase (Heriche et al., 2003), though 
more recently a new mechanism has emerged, where CRL4Cdt2 targets E2f1 for rapid 
ubiquitination and destruction during S phase (Shibutani et al., 2008).  Orthologs of E2F7/8 
do not seem to exist in Drosophila. 
Despite the simpler E2F/DP/RB pathway in Drosophila, the existence of the 
multiple layers of the E2F suppression mechanisms raises the question: What are the 
biological consequences of disrupting E2f1 S phase-coupled destruction? 
 
Ubiquitin Mediated Proteolysis  
It is well established that ubiquitin-mediated degradation of proteins plays an critical 
role in various processes including cell cycle progression, transcription and DNA replication 
and repair (Nakayama and Nakayama, 2006). Recent evidence supports a growing role for 
the E3 ubiquitin ligase, Cullin-4, in conjunction with the substrate recognition factor Cdt2 
(CRL4Cdt2), for the degradation of multiple cell cycle-regulated proteins to in order to prevent 
hyper-proliferation, DNA damage, and eventual genomic instability (Abbas and Dutta, 
2011).  This ubiquitin-mediated proteolysis is required for normal cell cycle progression by 
destroying specific cell cycle proteins in order to maintain the coordinated oscillations 
required.  Here, we briefly highlight the current knowledge about the various roles of the 
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CRL4Cdt2 E3 ubiquitin ligase, and how its activity contributes both to normal cell cycle 
progression and to the preservation of genome integrity.  
 The ubiquitylation reaction involves the covalent attachment of the small 76 amino-
acid ubiquitin moiety on a specific lysine residue in the target substrate protein. For 
substrates destined for degradation via the 26S proteasome, polyubiquitin chains are 
assembled through the successive attachment of the ubiquitin molecules through the 
formation of isopeptide bonds between the C-terminus of the incoming ubiquitin to lysine 48 
of the attached ubiquitin (Havens and Walter, 2011).  The formation of this polyubiquitin 
chain marks the substrate protein for proteolysis. Polyubiquitylation is achieved through 
three distinct and consecutive enzymatic steps where ubiquitin is first activated by an E1 
ubiquitin-activating enzyme followed by the transfer of the activated (AMP-charged) 
ubiquitin from the E1 enzyme to an E2 ubiquitin-conjugating enzyme. Finally, the ubiquitin 
is transferred from the E2 enzyme to the substrate through the activity of an E3 ubiquitin 
ligase (Abbas and Dutta, 2011). The ability of E3 ubiquitin ligases to recognize, with high 
specificity, a relatively large number of substrates accounts for the diverse structural 
complexity of this group of proteins.  
 Cullin-RING E3 ubiquitin Ligases (CRLs) represent the largest and most complex 
family of E3 ubiquitin ligases and play significant roles in multiple physiological processes 
including transcription, differentiation, cell cycle control, proliferation, apoptosis and 
tumorigenesis.  This class of E3 ubiquitin ligases include cullin 1, 2, 3, 4A, 4B, 5 and cullin 7 
as well as the cullin-like proteins PARC and APC2 (Abbas and Dutta, 2011; Baker, 2007). 
Several CRLs and many of their target protein substrates are conserved throughout evolution.  
The core CRL4 ubiquitin ligase complex is composed of one of two scaffold proteins (Cul4A 
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or Cul4B), Ddb1 (damage-specific DNA binding protein-1), an adaptor protein which 
functions to bridge one of many substrate recruiting factors (DCAFs; Ddb1 and Cul4 
Associated Factors) to the Cul4 E3 subunit, and a small RING finger protein (Rbx1/2) 
required for the recruitment of a corresponding E2 ubiquitin-conjugating enzyme (UBC) 
(Jackson and Xiong, 2009).  There are at least 49 known DCAFs or WDR (WD repeat-
containing proteins) proteins that function as substrate recognition factors to recruit 
substrates to the CRL4 ubiquitin ligase complex (Higa et al., 2006b). 
The CRL4 E3 ligase orchestrates a variety of physiological processes including DNA 
replication, transcriptional regulation, apoptosis and a number of DNA repair processes.  
Recent work demonstrated that CRL4 is critical for preventing genomic instability through 
its ability to promote the ubiquitin-dependent proteolysis of Cdt1, a replication initiation 
protein that is essential for pre-RC (pre-replication complex) assembly and the recruitment of 
the replicative helicase MCM2-7 at replication origins (Abbas and Dutta, 2011; Havens and 
Walter, 2009; Higa et al., 2006a).  Cells that are deficient in Cul4 exhibit re-replication and 
genomic instability reminiscent to that seen in cells overexpressing the replication initiation 
factor Cdt1 (Arias and Walter, 2005; Jin et al., 2006).  
Following Cdt1, a small but growing list of proteins have been shown to be targeted 
for destruction by CRL4Cdt2 ubiquitination.  CRL4Cdt2 promotes the ubiquitin-dependent 
degradation of several of its substrates not only in response to genotoxic stress, but also in 
unperturbed proliferating cells, specifically during the S phase of the cell cycle. The CDK 
inhibitor p21 (Jorgensen et al., 2011; Nishitani et al., 2008), the histone monomethyl 
transferase Set8/Pr-Set7, the C. elegans the bypass polymerase, (Acharya et al., 2008), and 
Drosophila E2f1 (Shibutani et al., 2008) have been shown to be targets.  While these proteins 
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seem to have a variety of roles, they all coalesce on regulation of cell cycle progression, 
arrest following genotoxic stress, and overall maintenance of genome integrity (Havens and 
Walter, 2011).   The coupling of destruction of these proteins via CRL4Cdt2 to a specific 
phase of the cell cycle or after DNA damage relies on an elegant coupling of this mechanism 
to chromatin loaded PCNA (Arias and Walter, 2006).  Recent crystal structure studies have 
shown that only once PCNA (Proliferating Nuclear Antigen) is associated with chromatin, 
there is the formation of the appropriate hydrophobic pocket that can recognize a specific 
amino-acid sequence referred to as the PIP degron (Havens and Walter, 2009).  This degron 
contains both amino acids that interact with chromatin loaded PCNA (PIP box), as well as 
amino acids that extend into the nucleoplasm to recruit the substrate receptor, Cdt2, initiating 
the recruitment of the entire CRL4Cdt2 complex.  The PIP degron is highly conserved between 
all CRL4Cdt2 targets and temporally connects the destruction of these substrates to S phase, as 
well as after DNA damage, when DNA replication relies on PCNA loading (Figure 1.2). 
Figure 1.2: PIP Degron Interacts with Chromatin Associated PCNA  A) Structure of chromatin associated 
PCNA demonstrating hydrophobic pocket in which PIP degrons interact.  Amino acids in red associate directly 
with PCNA pocket, while amino acids shown in blue extend into the nucleoplasm and interact directly with 
substrate receptor protein, Cdt2.  Figure from (Havens and Walter, 2009) B) Conservation of PIP degron among 
five target proteins.  Colors of amino acids are the same as in A.  PIP3A mutation in Drosophila E2f1, the 
substitution of three amino acids for alanine, completely blocks E2f1 S phase coupled destruction.  
 
Drosophila embryos as an experimental model for studying E2F1 regulation 
 
The various stages of Drosophila development provide an excellent model system to 
study the mechanism of E2f1 regulation in different contexts. The various cell cycle 
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pathways and regulations have been well-characterized in Drosophila embryogenesis (Lee 
and Orr-Weaver, 2003). In addition, we can take advantage of mutant fly resources and 
genetic tools, with which we can manipulate many aspects of the cell cycle in vivo. 
The first 13 cycles of Drosophila embryogenesis are synchronous, rapid S-M cycles 
that lack obvious gap phases. These cycles are driven by maternal supplies of mRNAs and 
proteins (Foe and Alberts, 1983). After the S phase of cycle 14, the first gap phase G214 
appears. It has been shown that G214 is caused by the degradation of maternal string (stg) 
mRNA and protein (Edgar and Datar, 1996). Stg is a Drosophila ortholog of Cdc25 
phosphatase that activates CDK1 by removing the inhibitory phosphates. Stg is required for 
the G2-to-M transition, so that the degradation of maternal stg causes G214 introduction 
(Edgar and O'Farrell, 1989; Sigrist and Lehner, 1997). After gastrulation begins, the 
developmentally-regulated transcription of zygotic stg regulates the entry into mitosis during 
cycles 14, 15 and 16 (Edgar et al., 1994; Edgar and O'Farrell, 1990).  After cycle 16, the first 
G1 phase appears in the epidermal cells of the embryo (G117), whereas the cells in the central 
nervous system (CNS) continue the S-G2-M cycle, and the cells in the midgut enter a G1-S 
cycle called the endocycle (discussed in Chapter IV).  
The initiation of G1 phase is achieved by the developmentally-regulated transcription 
of dacapo (dap), which encodes the single Drosophila p27-like CDK inhibitor (de Nooij et 
al., 1996; Lane et al., 1996). Dap induces G117 because it specifically inhibits CycE/CDK2, 
which is required for entry into S phase. The G117-arrested epidermal cells remain in G1 for 
the rest of embryogenesis, and this maintenance of G117 requires the function of RBF1 (Du et 
al., 1996a).  Interestingly, it is only after the onset of zygotic transcription that E2f1 is 
cleared from S phase cells.  Prior to this onset, E2f1 protein may co-localize with BrdU 
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positive cells (Shibutani et al., 2007), however following the first gap phase (G214), E2f1 is 
targeted for destruction upon subsequent S phase entry (Figure 1.2B).  The mechanism that 
activates this destruction upon zygotic expression is as yet unknown, but will be discussed 
further in the future directions.   
 
Figure 1.3: Drosophila embryonic cell cycles and E2f1 Destruction  A) Schematic of various cell cycle s 
utilized during Drosophila embryonic development. B) A 3-5 hour wild type (w1118) embryo.  BrdU (green) is 
a nucleotide analogue that incorporates into replicating DNA and labels cells undergoing S phase.  E2f1 protein 
(red) as measured by a polyclonal antibody generating by the Duronio lab.   Those cells in the midline marked 
with BrdU have entered S15, the first S where E2f1 is targeted for destruction.  The onset of this mechanism is 
still unclear and will be discussed later.  
 
Drosophila Imaginal Discs as an Experimental Model for Studying Tissue Homeostasis 
 During the development of homometabolous insects such as Drosophila 
melanogaster, specific cells are fated during embryogenesis to contribute to adult structures 
(Baker, 2007).  These are called imaginal cells and make up imaginal tissues that are 
contained within the body of larvae.  During pupation, these tissues are often broken down 
but will provide the signals and tissues to rapidly grow the correct adult structure.  Polarity, 
symmetry, and size cues are established during larval and embryonic development (Figure 
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1.3).  Imaginal tissues have long served as an important tool for understanding the 
mechanisms controlling cell cycle regulation, size determination, and development.  We will 
focus on wing imaginal discs and eye imaginal discs as they provide distinct advantages for 
the analysis of stabilization of E2f1 protein on normal tissue homeostasis.   
 
Figure 1.4: Drosophila Larval Imaginal Structures Schematic of the imaginal tissues found in Drosophila 
larvae during development and the adult structures they give rise to.  Discussed further in this chapter are wing 
and eye discs.  
 
Imaginal Wing Discs 
Initiating as an approximately 50 cell-primordium, wing imaginal discs will undergo 
rapid mitotic cell cycles to proliferate to a nearly 50,000 cell epithelial monolayer at the end 
of larval development (Neufeld et al., 1998).  Upon pupation, this disc will give rise to the 
adult wing.  During larval growth, cell cycles are rapid and asynchronous, with an estimated 
total of 9.1 cell divisions (Martin et al., 2009). Early divisions occur 5.5 hours per complete 
cell cycle, while cycles may extend to nearly 30 hours towards late larval development.  
There are specific polarity patterns established during imaginal disc origination that will 
persist throughout larval growth and dictate the orientation of the adult wing.  These patterns 
are carried out by spatial expression of several secreted proteins, such as hedgehog, wingless, 
 14 
and decapentaplegic (Neufeld et al., 1998).  The most prominent is the formation of the 
anterior and posterior compartments, which is established within the wing primordial and 
persists until the adult structure.  Due to their well-characterized cell cycle profiles and 
developmental patterning, imaginal wing discs have long served as an excellent model for 
understanding rapidly proliferating developing tissues and which molecular mechanisms are 
at work to ensure their homeostasis.  Interestingly, there is relatively little apoptosis seen 
normally in developing disc tissues.  It has been shown, however, that these cells are poised 
to enter programmed cell death pathways in response to cells which have atypical cell 
division rates or acquired genomic damage.  Despite robust apoptosis, these discs are able to 
form the correct adult structures.  Recent work has shown that UV damage which results in 
up to 50% cell death within the imaginal disc can still result in a normal adult wing (Rusconi 
et al., 2000).  The mechanism at work is known as compensatory proliferation, which is 
discussed further later.  Due to all these characteristics, imaginal wing discs have served as 
an excellent model to study the balance of proliferation, arrest, and apoptosis required for 
complex tissues to develop rapidly.   
 
Imaginal Eye Discs 
 Unlike their relatively unorganized cell cycle program of the wing, the eye imaginal 
disc is exquisitely useful due to its’ precise spatial and temporal cell cycle patterns (Roignant 
and Treisman, 2009).   This disc arises from an approximately 20 cell epithelial primordium 
in the embryonic blastoderm.  By late larval development, the disc contains nearly 2000 cells 
and has a distinct pattern of differentiation.  A dorsal ventral furrow forms and progresses 
from posterior to anterior, driven by hedgehog function (Baker, 2007).  This furrow is the 
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area where specific cells differentiate to a photoreceptor fate.  Those cells anterior to the 
furrow are synchronously dividing, but without any pattern.  Cells within the furrow are 
arrested in G1, and as the furrow progresses, some cells re-enter the cell cycle in what is 
called the second mitotic wave (SMW) while others differentiate into various photoreceptor 
cell populations (Roignant and Treisman, 2009).  The power of analyzing the effects of E2f1 
stabilization in this tissues falls with the genetic tool, GMR-gal4.  This activator promotes 
UAS dependent gene expression only after the morphogenic furrow has progressed 
posteriorly.  Therefore, it allows precise, acute, measurements of the consequences of 
stabilized E2f1 protein.  Previous studies have investigated the role of E2f1 in the eye disc.  
Asano and colleagues showed that the heat shock-induced expression of Drosophila E2f1 in 
the eye disc induces apoptosis.  However, the cells within or anterior to the morphogenetic 
furrow did not undergo E2f1-induced S phase or subsequent apoptosis (Asano et al., 1996). 
 
Cell Competition, Apoptosis, and Compensatory Proliferation in Development and 
Cancer 
  Developmental biologists began studying the role of cell competition on normal 
development in multicellular systems when Morata and Ripoli (Morata and Ripoll, 1975) 
utilized the well-characterized development of Drosophila wing discs to uncover dominant 
mutations called “Minute.”  These mutations reduce the rate of cell division in a cell-
autonomous manner.  Therefore the heterozygous mutants develop more slowly, yet are 
viable and eventually reach normal body size.  By studying clones of heterozygous cells 
surrounded by wild-type neighbors, they discovered that minute mutant cells were eliminated 
from the clones, and replaced with wild-type cells from the surrounding tissue.  They noticed 
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that surrounding cells were dividing with greater frequency to replace the slow growing 
minute mutant cells.  This observation was called “cell competition.”  Interestingly, this 
process has been implicated in cells with tumor-suppressor mutations being replaced by 
surrounding wild-type cells as an intrinsic tumor-suppression mechanism to eliminate 
precancerous cells (Tamori and Deng, 2011).  However, this mechanism requires that cells 
are able to sense mutant cells and clear them from the population, while relying on 
compensatory proliferation to fill the resulting gaps to ensure normal tissue homeostasis.   
A recently well-studied example of this process is termed “compensatory 
proliferation.”  In this situation, instead of slow growth, certain cells are cleared from the 
tissue via apoptosis (Martin et al., 2009).  However, as they undergo the well-controlled 
cascade responsible for the activation of apoptosis, specific extra-cellular mitogens are 
released from the dying cells and initiate proliferation of neighboring cells (Rusconi et al., 
2000).  This cell-cell communication is critical to ensure those dying cells are replaced and 
there are a sufficient number of cells for tissue formation, but also allows that developing 
tissue to cull cells which may have acquired mutations that could have potentially deleterious 
consequences on the overall health of the organism.  Cells that have induced apoptosis, but 
are prevented from carrying out the complete program via expression of the baculovirus p35 
pan-caspase inhibitor result in what has been called “undead” or “zombie” cells (Martin et 
al., 2009).  These cells initiate compensatory proliferation, but as they are not cleared from 
the tissue, continue to signal and lead to eventual hyperplasia.   
 Tumors initiate when proliferation is uncontrolled, often by transformed cells with 
activated oncogenes or inactivated tumor-suppressor proteins, and malignant neoplasias arise 
from these mutant cells that have lost the ability to assemble and form normal functional 
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tissues (Weinberg, 2007).  Cancer, therefore, is a disease that arises when mutations affect 
intrinsic mechanisms of tissue-integrity and organ-size control.  Regulated cell competition, 
apoptosis, and compensatory proliferation act in concert drive sufficient proliferation to 
generate adult structures, and maintain those structures through the life of the organism, but 
also to prevent accumulated mutations from allowing proliferation to proceed unchecked.  
 
Dissertation Goals 
In this thesis, I will describe the work that I performed with my collaborators 
addressing the regulation of E2F1 activity during Drosophila development. In Chapter II, we 
present the specific details of two assays critical to our investigations, flow cytometry 
measurement of S phase coupled destruction of GFP tagged proteins in both Drosophila S2 
cells as well as dissociated Drosophila imaginal wing discs.  In Chapter III, we focus on the 
biological consequences of disrupting of S phase-dependent destruction of E2F1. We show 
that the destruction of E2F1 is required for the homeostasis of rapidly developing tissues, 
such as imaginal wing discs. Interestingly, the stabilization of E2F1 during S phase caused 
apoptosis, even when E2f1 was lacking activity as a transcription factor.  Instead, we propose 
a mechanism where E2f1/Rbf1 interactions act to induce apoptosis by relieving repression of 
a pro-apoptotic gene, hid. In Chapter IV, we describe a comprehensive review of the 
mechanisms behind and biological requirements for atypical cell cycles during normal 
development and in disease states.  We cover a wide spectrum of mechanisms for inducing 
endoreplication, possible functions in development, and scenarios where these atypical cycles 
could contribute to disease. In Chapter V, these results will be discussed in a broad context 
and ongoing research questions will be described.  
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 CHAPTER II 
IN-VIVO ASSAY OF S PHASE-COUPLED DESTRUCTION 
 
 
Preface  
 This work was previously published as an in depth technical article.  It is based on cell 
culture flow cytometry assays established by a former graduate student Shu Shibutani, and 
expanded by myself into imaginal discs dissociation FACS.  
The S2 flow cytometry assay was initally carried out by Shu Shibutani, and previously 
published (Shibutani et al., 2008).  I contributed to the writing of the manuscript while Robert 
Duronio conceived the project and finalized the manuscript.  I expanded this technique into 
dissociated imaginal discs to utilize this technique to measure cell cycle perturbances in-vivo.  
This was fundamental for experiments described in Chapter III as well as a significant 
contribution to a manuscript developed by a former graduate student, Harmony Salzler.   
 
 Davidson, JM., and Duronio, R.J. (2011). Using Drosophila S2 Cells to Measure S 
phase-Coupled Protein Destruction via Flow Cytometry.  Methods in Molecular 
Biology (Clifton, NJ). 782: 205.   
 
 
Salzler, HM., Davidson, JM., Montgomery, ND., and Duronio, RJ. (2009) Loss of 
the histone pre-mRNA processing factor SLBP in Drosophila causes genomic 
instability and impaired cellular proliferation.  PLoS One, 4(12), e81
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Abstract   
Cell proliferation depends on the timely synthesis and destruction of proteins at 
specific phases of the cell cycle.  Recently it was discovered that the destruction of several 
key cell cycle regulatory proteins during S phase is coupled directly to DNA replication.  
These proteins harbor a motif called a PIP degron that mediates binding to chromatin bound 
PCNA at replication forks and recruits the CRL4Cdt2 E3 ubiquitin ligase.  These interactions 
comprise an elegant mechanism for coupling DNA replication with ubiquitylation and 
subsequent proteolysis by the 26S proteasome.  Here we describe a flow cytometry-based 
method using Drosophila S2 and wing imaginal discs cells that recapitulates S phase-specific 
protein proteolysis.  Because of the high degree of evolutionary conservation of the PIP 
degron and CRL4Cdt2 and the ease of culturing and inhibiting gene function by RNAi in S2 
cells, as well as the genetic tools available in-vivo, our flow cytometric method should serve 
as a general tool for determining whether any eukaryotic protein is subject to replication-
coupled protein destruction. 
 
Introduction 
Accurate progression through the cell cycle depends on the timely synthesis and 
destruction of a myriad of proteins.  A classic example is the B-type cyclins, which are 
targeted for destruction via the APC/C E3 ubiquitin ligase complex during the metaphase to 
anaphase transition to ensure completion of mitosis.  Cell cycle regulators are also targeted 
for destruction in other phases of the cell cycle.  Recently it was discovered that the 
proteolysis of a small set of proteins is coupled directly to DNA synthesis occurring during S 
phase or DNA repair. These proteins include the pre-replicative complex component Cdt1 
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(Arias and Walter, 2006; Hall et al., 2008; Higa et al., 2006; Hu and Xiong, 2006; Jin et al., 
2006; Nishitani et al., 2006; Senga et al., 2006), the cyclin-dependent kinase inhibitor p21 
(Abbas et al., 2008; Kim et al., 2008; Nishitani et al., 2008), the C. elegans translesion DNA 
polymerase Pol-H (Kim and Michael, 2008), and the Drosophila melanogaster transcription 
factor E2f1 (Shibutani et al., 2008).  There is increasing evidence that these proteins must be 
destroyed during S phase to ensure normal cell cycle progression.  
 The mechanism of destruction used by this group of proteins couples DNA 
replication with ubiquitin-mediated proteolysis.  Each of these four proteins contains a short 
(approximately 14 amino acid) motif called a PIP degron that is required for replication-
coupled destruction.  The PIP degron has two critical features:  a PIP box that confers 
binding to a hydrophobic pocket on PCNA (proliferating cell nuclear antigen) and key basic 
residues flanking the PIP box that recruit the multi-subunit CRL4Cdt2 E3 ubiquitin ligase, 
presumably through direct interaction with the substrate receptor, Cdt2 (Havens and Walter, 
2009).  PCNA loads onto DNA as a homotrimer and serves both as a processivity clamp for 
DNA polymerase during DNA synthesis and as a platform to recruit various PIP box-
containing proteins to replicating DNA (e.g. topoisomerase and histone deacetyltransferase) 
(Moldovan et al., 2007).  Current data support a model whereby proteins with a PIP degron 
interact with PCNA and become ubiquitylated by CRL4Cdt2 only when PCNA is assembled 
on chromatin at replication forks.  This results in an elegant mechanism for coupling ongoing 
DNA replication with ubiquitylation and subsequent proteolysis by the 26S proteasome 
(Figure 2.1). 
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Figure 2.1:  A model of CLRCdt2 mediated destruction of E2f1.  
 
 Drosophila E2f1 is a member of the E2F family of transcriptional activators, which 
play a pivotal role in the progression of the G1-S transition (van den Heuvel and Dyson, 
2008).  Like mammalian E2Fs, E2f1 is inhibited prior to S phase via interaction with the 
retinoblastoma protein (pRb) homolog, Rbf1.  Activation of cyclin-dependent kinases during 
G1 results in hyper-phosphorylation of Rbf1, thereby relieving E2f1 repression and 
activating a transcription program that promotes entry into S phase.  E2f1 is then rapidly 
destroyed during S phase (Asano et al., 1996; Heriche et al., 2003; Reis and Edgar, 2004; 
Shibutani et al., 2007).  We hypothesized that S phase-specific destruction provides an 
important Rbf1-independent negative regulation of E2f1.  In order to test this, we developed 
a facile method for using exogenous GFP-E2f1 fusion proteins and flow cytometry of 
cultured S2 cells that recapitulates the S phase-specific destruction of E2f1 observed in vivo.  
This method has the capacity to rapidly test whether specific domains within E2f1 or trans-
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acting factors (e.g. components of CRL4Cdt2) are required for destruction of E2f1 during S 
phase.  Our assay allowed us to discover a PIP degron within E2f1 and to demonstrate that 
PCNA and CRL4Cdt2 are necessary for S phase-specific destruction of E2f1 (Shibutani et al., 
2008). 
 In this chapter we describe our method for determining whether a protein is destroyed 
specifically during S phase and whether this destruction requires components of the CRL4Cdt2 
E3 ligase.  We discuss the method of generating stably transfected S2 cell lines, generating 
and treating those cell lines with dsRNA that will knockdown components of the CRL4Cdt2 
E3 ligase, inducing expression of GFP-fusion proteins, and submitting fixed and stained cells 
to flow cytometric analysis to ascertain their cell cycle profile and quantitatively measure S 
phase-specific protein destruction.   Because of a high degree of evolutionary conservation 
and the ease of culturing and inhibiting gene function by bathing S2 cells in dsRNA, our flow 
cytometric method should serve as a general tool for determining whether any eukaryotic 
protein is subject to the replication-coupled, PIP degron/CRL4Cdt2-mediated destruction 
mechanism. 
MATERIALS 
Drosophila S2 Cell Culture: Drosophila S2 Cells (Invitrogen). SF-900  III SFM culture 
medium (Gibco, Invitrogen). Penicillin-Streptomycin: Solution stabilized, sterile-filtered, 
with 10,000 units penicillin and 10mg streptomycin/mL (Sigma, St. Louis, MO)., 25 cm2 
Corning Cell Culture Flasks (Sigma). Incubators with proper humidity (28°C/100% air 
incubator for normal growth, 37°C/100% for heat shock induction). 
Creating Double Strand RNA for RNAi: T7 RNA Polymerase (New England Biolabs),  
RNAsein Ribonuclease Inhibitor (Promega), 10x Transcription Buffer: 400mM Tris pH 
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8.0, 150 mM MgCl2, 50mM DTT, 0.5 mg/mL BSA.  DNase 1U/ul (Promega), NTPs set 
100mM Solutions (Fermentas), Phenol:Chloroform:Isoamyl Alcohol 25:24:1 saturated with 
10 mM Tris, pH 8.0, 1 mM EDTA. (Sigma Aldrich), dsRNA ladder (New England Biolabs), 
AlphaImagerTM 2200 (Alpha Innotech) and ImageQuant 5.2 software (GE Life Science) 
Generating Stable Lines: pHGW: Gateway-compatible destination vector developed by Dr. 
Terence Murphy (http://www.ciwemb.edu/labs/murphy/Gateway%20vectors.html). 
Available upon request.  This vector allows NH2-terminal GFP fusion driven by the Hsp70 
promoter, with Ampicillin resistance.  Other vectors allow COOH-terminal fusion, which 
may be necessary for certain proteins depending on the stability of the fusion protein and the 
location of the PIP degron (e.g. NH2-terminal GFP fusion may mask an NH2-terminal PIP 
degron). Gateway LR Clonase II enzyme (Invitrogen). pCoHygro plasmid (Invitrogen) 
4526bp with Ampicillin resistance.  Hygromyosin B (Invitrogen). Amaxa Nucleofectin V 
for Drosophila S2 Cell transfection (Lonza). Nucleofector apparatus (Lonza). 6 well 
culture plate (Corning). 2ml round bottom tubes (Eppendorf). 25cm2 cell culture flasks 
(Corning).  
Fixing S2 Cells: 32%  Paraformaldehyde (Electon Microscope Sciences), 1X PBS-T: 1X 
Phosphate Buffered Saline with 1%/vol Tween20 (Promega), DNase-free RNase (Roche), 
Propidium Iodide: 1.0 mg/mL solution in water (Invitrogen), store at 4° C protected from 
light.   
Flow Cytometric Analysis: Dako CyAn Flow Cytometry System (Dako, Beckman-Coulter), 
Summit 4.3 Flow Cytometer Data Collection software (Dako, Beckman-Coulter), Falcon 35-
2002 round bottom 6-mL polystyrene tube 12x75mm2.  If using a different flow cytometer 
system, use appropriate tube required for that cytometer. ModFit LT™ (Verity Software 
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House) Required parameters: height and area of fluorescence emission signal for GFP or 
propidium iodide signal.  Height of forward and side scatter.   
6.  Nomenclature: Forward Scatter (FS); parameter to measure light scattered less than 10˚ 
FS measures relative cell size.  Side Scatter (SS); light scattered at a 90˚ angle.  Measures 
complexity of cellular membranes combined to measuring clumping of cells.  Height (H) is 
the maximum amplitude of the emission signal.  Area (A) is the area of the signal.  Event 
Count measures the number of cells within to a certain parameter.  
METHODS 
Maintaining Drosophila S2 Cells in Culture 
Cells were routinely grown at room temperature in SF-900 Drosophila medium 
(Gibco) without serum and 1:200 Penicillin-Streptomycin (5 units/ml Penicillin, 5 µg/ml 
Streptomycin, Sigma). Schneider’s Drosophila medium (Gibco) supplemented with 10% 
Fetal Bovine Serum (Sigma) can also be used, but may interfere with RNAi and transfection 
efficiency. There are many multiparameter flow cytometer systems available that are 
functional to collect cell cycle data.  The main requirement is that the system be able to 
excite and detect GFP signal versus Propidium Iodide (PE) staining.   Similarly, many 
operating systems are publically available for cytometric analysis, including FlowJo 
(TreeStar) and TestDNA (Verity Software).  
Passage cells when density is between 6 to 20 x 106 cells/mL and split at 1:2 to 1:5 
dilution.   S2 cells do not grow well when seeded at a density below 5 x 105 cells/ml. Cells 
will being to disassociate from the flask when overcrowded, however these cells are still 
alive.  It is a good idea to avoid allowing the cultures to become overcrowded.  
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Simple laminar flow hoods are sufficient when working with Drosophila S2 cells, as they are 
not thought to carry vectors of human disease.  However, good sterile technique should be 
utilized to prevent contamination of the cells.  Once contaminate, there is little to no 
possibility of recovery.  Therefore, it is a good idea to freeze an aliquot of all cell lines 
generated.  We recommend freezing 2 x 107 cells from a single plate in 2.5 mL of freezing 
medium in 5 x 0.5 mL aliquots and storing in liquid nitrogen.  When removing cells from the 
flask, tap the flask several times to dislodge adherent cells.  Use a pipette to wash the surface 
where cells adhere before transferring cells to a new flask.  
Creating double-strand RNA and RNAi on S2 Cells 
Generate primers to amplify target genes using primers that contain a T7 promoter 
sequence (labeled in Italics).  Below are the sequences used to generate dsRNA against 
components of the CLR4Cdt2-mediated destruction machinery.  Note that an extended 
knockdown of PCNA is predicted to eventually result in an S phase arrest, thereby 
precluding detection of S phase-coupled destruction because of a depletion of S phase cells 
from the population.  However, we were able to find conditions of PCNA knockdown that 
stabilized E2f1 during S phase prior to extensive cell cycle arrest (Shibutani et al., 2008). A 
similar situation occurs with Cul4 knockdown, which eventually will result in G1 arrest. 
a. Cul4 dsRNA Forward: 
TAATACGACTCACTATAGGGTTGGCCAAACGATTACTTGTGGG 
b. Cul4 dsRNA Reverse: 
TAATACGACTCACTATAGGGGAGAAGATTATGGCTCAGCG 
c. Cdt2 dsRNA Forward: 
TAATACGACTCACTATAGGGGCGGGCTCCGGCATACGCGGC 
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d.  Cdt2 dsRNA Reverse: 
TAATACGACTCACTATAGGCGTGGCTGGAGCCCCAGGCCACG 
e. PCNA dsRNA Forward: 
TAATACGACTCACTATAGGGCAGGCCATGGACAACTCCCATG 
f. PCNA dsRNA Reverse: 
TAATACGACTCACTATAGGGTGTCTCGTTGTCCTCGATCTTGGG 
Double stranded RNAs (dsRNAs) are transcribed from PCR products generated by 
gene-specific primers containing T7 promoter sequences. PCR products are amplified from 
genomic DNA or cDNA clones. cDNA clones are available from the Drosophila Genomics 
Resource Center (https://dgrc.cgb.indiana.edu/). RNAi causes a reduction in gene expression 
and is not equivalent to a complete loss of function.  Western blot analysis after dsRNA 
treatment is recommended to determine the efficiency of knockdown.  Various responses to 
RNA interference occur depending on the threshold of activity necessary for each particular 
gene product.    
Transcription reaction is performed by combining the following: 2mM (final 
concentration) each NTP, 10µL 10x Transcription Buffer, 0.5 µl RNasein, 1 µg purified 
DNA template (e.g. via phenol:chloroform extraction), 1 µl T7 RNA polymerase with sterile 
water to make 100µl total reaction volume.  Incubate at 37˚ C for 6 hours (reaction may 
become cloudy). Add 1µl DNase and incubate at 37˚C for 30 minutes.  Annealed RNA 
strands are generated by boiling samples in a beaker of water to remove secondary structure 
and slowly returning to room temperature.  Purify dsRNA reaction using 
phenol:chloroform:isoamyl alcohol 25:24:1.  
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Approximate concentrations of the dsRNAs are determined by comparing the 
intensity of band of 1µl of RNA sample in an agarose gel using a dsRNA ladder as a 
standard. The intensity of the RNA bands is analyzed using by imaging the AlphaImagerTM 
and quantified with the ImageQuant 5.2 software.  Since RNase is highly ubiquitous and 
ssRNA is unstable, we recommend wearing gloves and maintaining a clean environment 
when working with RNA.   DEPC-treated water and RNAse-free plastics should be used 
when generating dsRNA.  dsRNA itself is fairly stable, however multiple freeze-thaw cycles 
should be avoided. 
Generating Stable Lines  
The open reading frame of wild type Drosophila E2f1 was amplified from pUAST-
E2f1 and cloned into pENTR/D-TOPO.  The forward primers used to amplify E2f1 are 
designed with a CACC at the 5’ end for directional cloning into pENTR.  To create 
expression vector plasmids, pENTR E2f1 was recombined with the Gateway expression 
vector pHGW, which contains an NH2-terminal GFP tag and a Hsp70 promoter, using the 
Gateway LR Clonase II enzyme mix.  Split cells 2-3 days prior to transfection to ensure 
they are growing well and not overcrowded.  Ensure that the entire Nucleofector 
Supplement is added to the Nucleofector Transfection solution and allowed to reach room 
temperature prior to beginning transfection protocol.  The transfection solution should be 
kept at 4°C otherwise and will expire within 3 months of the supplement being added.  
Prepare 6-well plates by filling appropriate number of wells with 1ml of SF-900 SFM 
culture media and allow it to come to room temperature.  Count an aliquot of cells and 
determine density.  Use 1x106 cells per sample, and spin down at 500xg for 5 minutes at 
room temperature.  Completely remove supernatant and flick tube to break up pellet.  
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Resuspend cells in 100 µl room-temperature Nucleofector Solution per sample.  Avoid 
leaving cells in this solution for longer than 15 minutes.  Combine cell solution with 2 µg 
pENTR E2f1 and 0.5 µg pCoHygro and transfer solution to cuvette supplied in 
Nucleofection Kit V, ensuring cell/DNA solution covers bottom of the cuvette with no air 
bubbles.  Close cuvette with cap.   
Select Nucleofector Program G-030.  Insert cuvette into apparatus and apply the 
program by pressing the X-button. Take cuvette out once transfection is successfully 
completed.  Immediately add 500 µl of room temperature SF-900 SFM media to cuvette and 
gently transfer to prepared 6 well plate, using supplied pipettes.  Final volume is 1.6 
mL/well.  Incubate cells in a humidified 25°C/100% air incubator without C02 for 2-3 days.  
Collect cells and centrifuge for 5 minutes at 500xg.  Replace with 2mL of fresh SF-900 SFM 
media and transfer to a new 6 well plate.  Let grow 2-3 days in a humidified 25°C/100% air 
incubator. 
Collect cells into two 2mL round bottom Eppendorf tubes and centrifuge for 5 
minutes at 500xg.  To one sample, add 2mL of SF-900 SFM with 50µg/mL Hygromyosin B.  
To the other, add only SF-900 SFM, in case selection kills the culture.  Grow in 6 well plate 
for 2-3 days in humidified 25°C/100% air incubator.  Other selection methods are available. 
Methotrexate resistance plasmids: pHGCO, pHCO, p8hCHO, actDHFR, (available from 
Drosophila Genomics Resource Center (DGRC)).  Methotrexate (Sigma) (L-amethopterin) 
used at a final concentration of 2 x 10-7 M (store stock solution protected from light at -20°).  
α-Amantinin resistance plasmids: pPC4 is available at DGRC. α-Amantinin is used at a final 
concentration of 5-10 µg/mL. Blastocidin S resistance: pCoBlast (available from Invitrogen). 
Blastocidin S used at approximatedly 5 µg/mL (per Invitrogen).   
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Once cells reach confluency within several days, transfer to 25 cm2 cell culture flask 
and split cells 1:5  every week.  Maintain 50mg/mL Hygromyosin B in SF-900 SFM media.  
Initial transfection efficiency should be around 50-60%, this can be checked by removing an 
aliquot, subjecting the cells to a 37°C heat shock for 30 minutes, waiting an hour and 
visualizing GFP signal under a microscope.  Once population is nearly homogeneous for 
containing the plasmid, experiments may begin.   
RNAi and Heat Shock Induction   
3-4 days prior to the experiment, count and plate stably transfected pHGW-E2f1 and 
pHGW-only cells at 1x106 cells/mL.  Add 1mL to each well of a 6 well plate.  Let cells grow 
overnight in a humidified 28°C/100% air incubator.  The following day, add the appropriate 
amount of dsRNA.  The normal range of dsRNA is 2-30 µg dsRNA per treatment (e.g. Cul4 
knockdown required 2µg whereas Cdt2 and PCNA required 10 µg).  Treat each sample with 
dsRNA two consecutive days while incubating at 28°C/100% air.  A non-specific control 
(e.g. LacZ) should also be used to measure effect of dsRNA treatment.  A subset of the cells 
may be collected and lysed for western blot analysis to measure efficiency of dsRNA 
knockdown. Optimization of the amount of dsRNA, and length of treatment, required to 
sufficiently knockdown a protein of interest may be required.   Prior to heat shock induction, 
a control sample of cells may be taken to measure baseline cell cycle profile.   
Transfer the rest of the cells to a 37°C/100% air incubator for 30 minutes to induce 
Hsp70 expression.  After 30 minutes, return cells to 28°C/100% air incubator and remove 
cells for appropriate time course. 
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Fixing S2 Cells for Flow Cytometric Analysis 
 Collect all the cells from each well by pipetting gently up and down and transfer each 
to a labeled 2ml round bottom Eppendorf tube.  Centrifuge tubes for 5 min at 500xg.  Pour 
out supernatant, flick tube gently to break up pellet. Wash cells with 500µl 1X phosphate 
buffered saline solution (PBS), centrifuge 5 minutes at 2300 rpm and gently tap tube to break 
up pellet.  Add 500 µl 1% paraformaldehyde in ice cold 1X PBS and keep on ice for 30 min.  
Make the paraformaldehyde solution immediately prior to use by combining 700µl 10x PBS, 
218µl 32% paraformaldehyde stock solution and bringing total volume to 7 mL.  Centrifuge 
tubes at 4° for 5 minutes at 500xg.  Remove paraformaldehyde solution into proper waste 
container.  Gently tap tube to break up pellet.  Wash cells with ice cold 1X PBS.  Centrifuge 
tubes at 4° for 5 minutes at 500xg, pour out supernatant and flick to break up pellet.  Add 
500µl 1X PBT (PBS with 0.1% Tween20), let sit 15 minutes at room temperature. This 
increases the permeability of the cell membranes. Centrifuge for 5 minutes at 500xg at room 
temperature. Remove supernatant and tap tube to break up pellet.  Add 3ul DNase-free 
RNase. Incubate for 30 minutes at 37° C.  It is critical to degrade RNA as propidium iodide 
binds equally to DNA and RNA.  Add 5µl 15 mM Propidium Iodide and 500µl ice cold 1X 
PBS.  Leave at 4° C overnight.  Fixed and stained cells can be kept up to a week until flow 
cytometric analysis, kept at 4° C and protected from light.  Propidium iodide is a DNA 
intercalating agent and must therefore be treated appropriately and discarded in a suitable 
manner. 
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FLOW CYTOMETRIC ANALYSIS OF S2 CELLS 
We recommend proper training from be received prior to beginning a flow cytometry 
experiment.  The following method outlines a protocol for measuring cell cycle profiles in S2 
cells on a CyAn (Dako, Beckman Coulter), but does not address all the complexities of flow 
cytometric analyis or the various other operating systems that can be used.  
Transfer all cells to Falcon tubes appropriate for the flow cytometer being used.  
Break up any clumps of cells prior to analysis by gently vortexing tubes.  Establish the 
correct protocol using Summit 4.3 software.  GFP detection uses a 488-nm laser and 
detection through a 530/30 bandpass filter.  Propidium iodide uses a 488-nm laser and 
detection through a 630/30 bandpass filter.  Create an acquisition template with plots by 
selecting “Create Histograms” from the menu options and create the following plots 
measuring the following parameters (x and y axis respectively):  SS Area vs. FS Area, PI Lin 
vs. PI Area, PI Area vs. GFP Log, Event Count vs. GFP Log, Event Counts vs. PI Area, Even 
Count vs. PI Area (of only GFP positive gate).   Save this template as a new protocol (Figure 
2.2).   
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Figure 2.2: Gating protocol for generating a cell cycle profile of Drosophila S2 cells, and measuring GFP 
fluorescence intensity using Summit software (X and Y-axis respectively).  A: SS Area vs. FS Area.  Gate 
R1 and R4 to collect only cells, not debris.  B: PI Linear vs. PI area.  Gate R2 to only collect single cells, not 
doublets or triplets, which may skew laser intensity readings.  C: GFP log vs. Counts on untransfected control 
cells. GFP laser intensity should be set so the peak falls between 100-101 .  D: PI Area vs. GFP log on 
untransfected control cells.  Set R3 gate so that no more than 0.05% of untransfected cells falls in the GFP 
positive range.  E: GFP log vs. Counts for GFP-E2f1 transfected cells.  Note shift of GFP intensity to 102 range.  
F:  PI area vs. GFP log measurement of GFP-E2f1 transfected cells.  Note shift of cell population now within 
the GFP positive gate (27% of all cells).  G: PI area vs. Counts of all cells measured. First peak (64) represents 
with G1, second peak (128) represents G2/M.  H: PI area vs Counts of GFP positive only cells.  Note that fewer 
cells appear in the area between the G1 and G2/M peaks, reflecting the targeted destruction in S phase of GFP-
E2f1.   
 
Using the Gate Logic Builder and the Gate Scheme applications, create the following 
gates on your histograms, as follows;  
a. SS Area vs. FS Area: Avoid bottom left corner where debris will be measured (R1).  
b. PI Lin vs. PI Area: Avoid doublets and clumped cells (R2).  
c. PI Area vs. GFP Log: Create a gate that will select only GFP positive cells (the 
threshold will be determined by running  the untransfected control).  
Under the Sample menu, assign a root file name, a starting file number and a data storage 
location. Limit total events collected (<1,000,000).  Under the Preferences menu, set 
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parameters to “Auto-Start” and “Auto-Boost.”  However, occasionally manual Boost will be 
required to activate the collection.  Run the untransfected control cells to set the GFP 
negative parameter.  Aim for less than 0.05% of cells falling above the GFP cut off in the 
untransfected samples.  Adjust laser voltage to generate single peak in the GFP Log vs. 
Counts histogram that falls between 100-101.   Adjust gates to ensure that no debris and only 
single cells are being collected. Once parameters are set for negative control, do not adjust 
for the remainder of the experiment.  
When acquiring cells, ensure that cells following “Boost” are not collected and cells 
run through the analysis between 200-400 cells per second.  Running the cells too quickly 
will decrease the accuracy of the data due to decreasing the time for excitation and detection. 
Run pHGW-only (GFP only) control to measure efficiency of transfection and heat shock 
induction.  Aim to collect at least 10,000 experimental events (GFP positive cells after all the 
gating). The minimum number needed for statistical analysis is 4,000.  20,000 cells is 
optimal.  Ensure that data is properly stored after each collection before starting the next.  
Take care that the gates ensure that only the experimental data is saved, not debris, which 
could quickly overfill your saving capacity.  In between samples, activate “Backflush” under 
the Acquisition menu to clear out any residual cells.  Rinse the CyAn uptake nozzle with 
distilled, deionized, water. 
 
DATA ANALYSIS 
There are two options for analyzing flow cytometry data to visualize cell cycle 
coupled destruction, such as is seen with Drosophila E2f1.  Visually, two histograms can be 
overlaid, using the Summit 4.3 software, and color labeled to distinguish the total cell 
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population as compared to the GFP-positive population alone.  This provides an easy way to 
quickly visualize S phase specific destruction.  
Figure 2.3: ModFit LT analysis.  A: Histogram representing the calculated percentage of cells in each phase 
of the cell cycle and the confidence in these values.  Shaded peaks represent the calculated profile of G1 and G2 
peaks, dashed lines represent the calculated percentage of cells in S phase.  B: The gating required to analysis 
flow cytometry samples (X and Y-axis, respectively).  Gate 1: SS area vs. FS area.  Gate 2: PI Linear vs. PI 
Area. Gate 3: Area PI vs. GFP Log.  Include all cells in this gate to get a total cell population profile, and gate 
only the GFP positive cells to measure the cell cycle profile of GFP-E2f1 transfected cells.  
 
To observe more subtle changes in the cell cycle, or for a more quantifiable approach, 
statistical software can calculate the percentages of cells in each phase of the cycle, in 
addition to apoptotic (i.e. sub-G1) cells.  This will be discussed further.  Open ModFit LT 
software and open the file to analyze.  Select Area PI as the Parameter for Analysis.  Define 
three gates as follows (X and Y-axis respectively): Gate 1: SS Area vs. FS Area.  Gate 2: 
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Linear PI vs. Area PI.  Gate 3: Area PI vs. Log GFP.  Adjust the gates to closely reflect how 
the data was collected (Figure 2.3).  
Initially, include all cells in Area PI vs. Log GFP gate.  This will give you the whole 
cell cycle profile.  Open Mod window to set the parameters.  For S2 cells, use the following 
constraints: Linearity: 1.93, Standards: 0, Number of cycles: 1, Model Template: Diploid, 
Range Positions: Compute Range Positions.  This will allow the computer to appropriately 
predict G1 and G2 peaks.  Utilizing Auto-Aggregation, Auto-Debris and Apoptosis modeling 
functions is depended on the samples and the data required.  Select Range, and adjust the 
automatically applied G1 and G2 ranges to most accurately fit the data.  Then select Fit, and 
the software will calculate the percentage of cells in G1, S, and G2/M.   The strength of 
confidence is an %CV value, which should be under 10 for high confidence in the data.  Low 
experimental cell numbers can reduce this confidence value.  
Repeat this with the GFP positive only cell population to compare the values.  A S 
phase-coupled destruction will result in a significant decrease in GFP positive cells in S 
phase.  RNAi that depletes a component of the destruction mechanism will result in a flow 
cytometry profile that resembles a GFP-only control.  Basic spreadsheet software (eg. Excel) 
can create graphical representations of the percentages of cells in each phase.  
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Figure 2.4: Representations of flow cytometric data.  A) Time course of induction of GFP and GFP-E2f1 
expression in stable S2 cell lines.  Overlay of total cell population (unfilled histogram) with GFP positive cells 
(filled histogram).  Time points taken before heat shock induction, and for representative time points.  Note that 
by 240 minutes after expression, an S phase coupled destruction of GFP-E2f1 is noticeable (arrow).  B) 
Graphical representation of data collected in ModFit analysis.  Percentages of cells in S phase of the total cell 
population compared to the GFP positive cell population, over the time course.  Note the sharp decline in GFP-
E2f1 cells.  Error bars represent one standard error.   
 
Flow Cytometric Analysis of Dissociated Imaginal Discs 
 A powerful application of this method utilizes dissociated imaginal discs instead of 
S2 cell culture to observe cell cycle conditions in a developing organism.  While many of the 
steps are similar as presented above, we will highlight the specific technique of obtaining and 
staining disociated cells.  This technique contributed significantly to the following chapter, as 
well as the work of a fellow lab mate, Harmony Salzler.   
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 Culture Drosophila according to normal protocol.  This method allows for either 
dissociation of the entire disc and measuring the effects of a specific mutant genotype 
(Salzler et al., 2009) or driving expression of a GFP-tagged transgenic protein in the posterior 
compartment of the imaginal disc using UAS/En-Gal4.  In either situation, it is best to grow 
robust cultures at room temperature, clear all wandering larvae at the beginning of the day, 
and then collect larvae which crawl up within a few hours to ensure they are all of the same 
stage.  Pick as many as you can feasibly dissect in 30 minutes.  In PBS, quickly dissect out 
the imaginal discs with out bringing any connective tissue or fat bodies.  Leaving the haltare 
disc attached is fine.  Transfer to an eppendorf tube after coating pipet tip with carcasses to 
ensure discs will not stick to pipet.   
 Aspirate PBS and replace with the following solution: PBS containing 0.05% 
Trypsin- EDTA (Gibco), and 1X Hoechst 33342 DNA binding dye (Sigma) and rock for 3 
hours on rotating platform.  Do not flick or vortex sample.  To verify dissociation, small 
aliquots can be removed and visualized with microscopy.  Once cells are nearly 
homogeneous, transfer to appropriate flow cytometry sample tube.  If there are visible 
clumps still present, pass sample gently through a 22 micron mesh filter.  Proceed with flow 
cytometry analysis.  However, instead of fixed cells and propidium iodine marking DNA 
content, these cells are unfixed and use Hoeschts which must be measured with a 335nm 
wavelength.  Therefore, it is imperative to quickly sort cells, as extended trypsinization 
results in cell death and to use a flow cytometer equipt with a UV laser Otherwise, 
parameters described above should be followed.   Again, it is possible to measure the effects 
of specific genotypes on the entire disc cell cycle profile, as shown below with SLBP 
mutants causing cell cycle defects (Salzler et al., 2009) relative to wild type.  
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Figure 2. 5 FACS analysis of wt and Slbp15 mutant wing discs.  Each bar represents the mean of three 
independent experiments where over 4,000 cells were analyzed per genotype.  
 
Conversely, one can measure the effects of transgenes only expressed in the posterior 
compartment, utilizing the anterior portion of the disc as an internal control.  This is 
acheieved by expressing GFP-tagged ectopic proteins with the En-Gal4 promoter.  This will 
be discussed much further in the following chapter.  
 
DISCUSSION 
 Here we present a detail methods protocol for utilizing S2 cells or imaginal discs and 
flow cytometry tools to measure the specific cell cycle regulated destruction of certain 
proteins. These tools have made significant contributions to several publications and will 
continue to be a critical technique in future investigations.  Future directions can include the 
dissociation with other imaginal tissues (such as eye discs) and measuring the proteolysis of 
other target proteins.  
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CHAPTER III 
BIOLOGICAL CONSEQUENCES OF E2f1 STABILIZATION 
 
 
PREFACE 
 
 This work is currently in press in the journal PLoS Genetics.  All experiments were 
conducted by myself, but this follows on work established by a former graduate student, Shu 
Shibutani (Shibutani et al., 2008).  The project was conceived and written by myself and 
Robert J. Duronio.  
 
 Davidson, J.M., and Duronio, R.J. (2012). “S Phase-Coupled E2f1 Destruction 
Ensures Homeostasis in Proliferating Tissues.”  PLoS Genetics (in press).  
 
 
ABSTRACT 
 
 Precise control of cell cycle regulators is critical for normal development and tissue 
homeostasis.  E2F transcription factors are activated during G1 to drive the G1-S transition, 
and then inhibited during S phase by a variety of mechanisms.  Here, we genetically 
manipulate the single Drosophila activator E2F (E2f1) to explore the developmental 
requirement for S phase-coupled E2F down-regulation.  Expression of an E2f1 mutant that is 
not destroyed during S phase drives cell cycle progression and causes apoptosis.  
Interestingly, this apoptosis is not exclusively the result of inappropriate cell cycle 
progression, because a stable E2f1 mutant that cannot function as a transcription factor or 
drive cell cycle progression also triggers apoptosis.  This observation suggests that the 
inappropriate presence of E2f1 protein during S phase can trigger apoptosis by mechanisms 
that are independent of E2F acting directly at target genes.  The ability of S phase-stabilized 
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E2f1 to trigger apoptosis requires an interaction between E2f1 and the Drosophila pRb 
homolog, Rbf1, and involves induction of the pro-apoptotic gene, hid.  Simultaneously 
blocking E2f1 destruction during S phase and inhibiting the induction of apoptosis results in 
tissue overgrowth and lethality.  We propose that inappropriate accumulation of E2f1 protein 
during S phase triggers the elimination of potentially hyperplastic cells via apoptosis in order 
to ensure normal development of rapidly proliferating tissues. 
 
Introduction 
During development, cells continually integrate extrinsic and intrinsic signals that 
control cell growth, proliferation and apoptosis.  Mitogenic signals that drive growth and cell 
proliferation are balanced with apoptotic signals that eliminate damaged or unneeded cells.  
Genetic changes that inappropriately stimulate cell proliferation, reduce apoptosis, or both 
disrupt this homeostasis and result in aberrant development or neoplastic diseases like cancer 
[1].  Understanding the mechanisms that exist to maintain such homeostasis is thus an 
important area of investigation.  
The balance between cell proliferation and cell death in growing tissues must 
ultimately function through key regulators of the cell cycle.  These regulators include the E2F 
family of transcription factors, which control the expression of many genes responsible for 
cell proliferation, differentiation and apoptosis [2].  E2Fs are highly conserved proteins that 
act as either activators or repressors of transcription based on protein partners and structural 
features.  As key mediators of cell proliferation and apoptosis, tight regulation of E2F activity 
is essential for normal development in mammals, flies, worms, and plants [2,3].  The best-
characterized mode of regulation involves members of the retinoblastoma (pRb) tumor 
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suppressor protein family, which bind to and inhibit those members of the E2F family that 
dimerize with DP proteins [2].  In addition, pRb family/E2F complexes function as 
transcriptional repressors [4].  Loss of pRb function causes ectopic proliferation and apoptosis 
that is partially repressed by reducing E2F activity [5]. 
pRb family regulation of E2F occurs in quiescent cells and during G1 phase.  Several 
pRb-independent mechanisms have been described that regulate activator E2Fs outside of G1, 
including Cyclin A/Cdk2-dependent phosphorylation of the DP subunit [6,7,8], SCFSkp2-
directed proteolysis [9,10], antagonism by the atypical E2F7 and E2F8 proteins [4,11,12], and 
binding to DP-4 [13].  These mechanisms are thought to down-regulate transcriptional 
activation by E2Fs during S phase or after DNA damage.  In particular, disruption of Cyclin 
A/Cdk2 phosphorylation of E2F1 causes S phase defects and apoptosis in mouse cells, as does 
simultaneous loss of E2F7 and E2F8 [7,8,11].  In addition, E2F7/8 mutation in mice results in 
lethality, indicating that E2F7/8 play an essential role in the E2F regulatory network during 
development [11].  Mouse mutant genotypes that would specifically determine the 
contribution to development of Cyclin A/Cdk2 phosphorylation or the other modes of pRb-
independent E2F inhibition have not been developed.   
Here we examine the function of pRb-independent E2F regulation in developing 
Drosophila tissues, where E2F regulatory pathways are simpler than in mammals.  While 
eight mammalian E2F genes encode nine distinct proteins (5 activators and 4 repressors), 
Drosophila encodes a single E2F activator (E2f1) and a single E2F repressor (E2f2), both of 
which bind the single Dp protein [2].  The primary cell cycle regulator is E2f1/Dp, which 
activates the transcription of replication factor genes and is negatively regulated by Rbf1, one 
of the two Drosophila pRb family members [14].  E2f1 mutant cells proliferate poorly 
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[15,16,17], in part because of E2f2-mediated repression [18,19].  Conversely, over-expression 
of E2f1 can drive cells into S phase [20,21,22].  E2f1 over-expression also induces apoptosis 
[17,20,21], and this may reflect the positive role E2f1 plays in developmentally controlled and 
DNA damage induced apoptosis [23,24,25,26].  While many S phase and apoptotic 
transcriptional targets of E2f1 have been described [27,28], the aspects of E2f1 regulation that 
coordinate the expression of these targets in rapidly growing tissues to achieve the proper 
balance of cell proliferation and apoptosis are not well understood.  
In addition to the evolutionarily conserved pRb mode of activator E2F regulation, 
Drosophila E2f1 is inhibited by rapid destruction during early S phase [20,29,30,31].  We 
recently determined that this S phase destruction is mediated by a “PIP degron” in E2f1 [32].  
PIP degrons promote direct binding to DNA-loaded PCNA and the subsequent recruitment of 
the CRL4Cdt2 ubiquitin E3 ligase, thereby coupling proteolysis with DNA synthesis that occurs 
during S phase or after DNA damage [33,34].  Drosophila E2f1 thus joined a small but 
growing number of proteins involved in genome duplication and maintenance that are 
regulated by CRL4Cdt2 [33,34].   
We previously demonstrated that expression of an S phase-stabilized E2f1 causes cell 
cycle acceleration, apoptosis, and developmental defects [32].  Because similar levels of wild 
type E2f1 expression, which is degraded during S phase, do not induce these phenotypes, we 
concluded that accumulation of E2f1 during S phase is poorly tolerated during development.  
However, we did not determine whether apoptosis and the developmental defects were a 
consequence of changes to the cell cycle in response to hyperactive E2f1 transcriptional 
activity, or to some other consequence of E2f1 accumulation during S phase.  To explore this 
issue, we used assays in larval imaginal discs to understand the in vivo consequences of 
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stabilizing E2f1 during S phase in developing tissues, focusing specifically on which activities 
of the E2f1 protein (e.g. DNA binding or Rbf1 binding) were responsible for the deleterious 
phenotypes resulting from stabilization during S phase.  
We demonstrate here that the apoptosis and developmental defects caused by 
accumulation of E2f1 protein during S phase do not require E2f1’s ability to induce 
transcription and cell cycle progression.  Instead, apoptosis may occur via alleviation of Rbf1-
dependent repression of the pro-apoptotic gene hid.  We also show that simultaneously 
stabilizing E2f1 in S phase and blocking apoptosis results in extensive tissue overgrowth.  We 
propose that inappropriate S phase accumulation of E2f1 protein in proliferating Drosophila 
cells triggers a form of proliferative stress, and that the cells experiencing this stress are 
consequently eliminated via apoptosis in order to prevent hyper-proliferation and maintain 
homeostasis during rapid tissue growth. 
MATERIALS AND METHODS 
Molecular Biology 
E2f1 constructs were generated and expressed using pENTR TOPO (Invitrogen) and 
Gateway-compatible P element vectors 
(http://www.ciwemb.edu/labs/murphy/Gateway%20vectors.html). 
Cell Culture and Transfection 
For S phase-coupled protein destruction analysis, S2 cells stably transfected with 
hsp70 constructs were heat shocked for 30 minutes at 37°C, which results in GFP or GFP-
E2f1 expression in all cells of the population, and allowed to recover at room temperature for 
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200 minutes prior to analysis by flow cytometry.  During the 200 min chase period GFP-E2f1 
is destroyed in S phase cells while GFP is not, as measured by the percentage of GFP(+) cells 
in each phase of the cell cycle.  For cell cycle analysis, S2 cells were transfected with plasmid 
DNA expressing GFP or GFP-E2f1 encoding mRNA from the Actin5C promoter and 
analyzed by flow cytometry 48 hours later.  
Flow Cytometry 
For flow analysis of wing imaginal discs, at least 15 third instar larvae of the 
appropriate genotype were dissected in PBS.  30 imaginal discs were collected and 
immediately dissociated in PBS containing 0.05% Trypsin- EDTA (Gibco), and 1X Hoechst 
33342 DNA binding dye (Sigma) and rocked for 3 hours at room temperature.  The 
dissociated tissue was then immediately analyzed using a LSRII Flow Cytometer and Diva 
software (Becton Dickinson).  Cell cycle profiles were calculated using FlowJoTM Software.  
Percentages of G1, S, and G2 cells were calculated using Modfit LT software (Verity 
Software House).  P values for all experiments were calculated by student’s T test. 
S2 cells stained with propidium iodide were analyzed by flow analysis as previously described 
[32] using the Cyan flow cytometer with Summit 4.3 software (Deko).  
qRT-PCR 
Total RNA was extracted from 30 third instar wing imaginal discs using Trizol reagent 
(Invitrogen) and tissue was sheared with eight passes through a 25-gauge needle.  0.75 ug of 
total RNA was used for reverse transcription with RevertAid Reverse transcription kit 
(Fermentas).  The resulting cDNA was used for qRT-PCR performed using an ABI prism 
7700 Sequence Detection system.  Relative levels of specific mRNAs were determined by 
detection of Maxima Sybr Green (Fermentas).  Primers are listed in Table 1.  Comparative CT 
 54 
methods were used to quantify levels versus control Rp49 mRNA using the manufacturer’s 
protocol.   
Drosophila genetics and cytology 
Transgenic flies were generated by injecting UASp-E2f1 plasmids into w1118 (Best 
Gene Drosophila Injection Services, Chino Hills, CA).  UAS-GFP, Engrailed-Gal4, UAS-
RFP and UAS-p35 stocks were obtained from the Bloomington Stock Center.  For antibody 
staining, imaginal discs were dissected from third instar larvae in PBS, fixed in 6% 
paraformaldehyde for 20 minutes at room temperature, then permeabilized for 20 minutes in 
PBS-1.0% Triton-X.   Wing discs were incubated overnight with mouse anti-GFP (1:1000, 
Abcam) and rabbit anti-cleaved Caspase-3 (Asp175) (1:200, Cell Signaling Technology) at 
4°C.  Secondary antibodies were goat anti-mouse Oregon Green 488 (1:2000 Invitrogen) and 
goat anti-rabbit Rhodamine (1:2000 Invitrogen) for 1 hour at room temperature.  Eye discs 
were dissected, incubated in 10ug/mL EdU (Click-iTTM EdU Alexa Fluor® 594, Invitrogen) 
for 30 minutes, fixed and permeabilized as described above.  EdU was detected according to 
manufacture protocol.  To detect mitosis, eye discs were incubated overnight at 4°C with 
rabbit anti-PH3 (1:1000, Abcam) and then with goat anti-rabbit Rhodamine (1:1000 
Invitrogen) for 1 hour at room temperature.  For DNA damage detection, rabbit anti-p-H2Av 
antibody from Kim McKim’s lab was incubated over night at 4°C at 1:1000 and then goat 
anti-rabbit Rhodamine (1:1000 Invitrogen).  DAPI was added for DNA detection (1:1000 
Invitrogen) for 2 minutes. Tissue samples were analyzed with a Zeiss LSM 510 scanning 
confocal microscope.   Quantification of CC3 and p-H2Av foci was collected by projecting 
confocal images that were one micron apart through the eye disc of 6 discs per genotype and 
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using ImageJ software to count all foci above threshold detection posterior to morphogenetic 
furrow.  7 images per disc projected for p-H2Av, 6 images per disc for CC3.  Graph shown 
represents the average number of foci of those 6 discs.    
Western Blot and Co-immunoprecipitation 
30 third instar larvae wing imaginal discs were dissected in PBS then dissociated by 
eight passes through a 25 gauge needle after addition of ice-cold NP40 buffer with protease 
inhibitors aprotinin (1:1000), leupeptin (1:1000) and PMSF (1:100).  E2f1 protein levels were 
measured with affinity-purified rabbit anti-E2f1 raised against full-length Drosophila E2f1 
(1:1000)[32] overnight at 4°C and anti-rabbit HRP secondary (1:10,000 GE Healthcare) for 1 
hour at room temperature.  B-tubulin was used as loading control (1:1000, Abcam) with anti-
rabbit HRP secondary (1:10,000 GE Healthcare).  Co-immunoprecipitation was performed by 
co-transfecting S2 cells with 2µg Myc-E2f1 and 1µg HA-Dp or HA-Rbf1 using the Amaxa 
transfection system (Lonza) and incubating the cells for 24 hours at 28°C.  S2 cells were lysed 
on ice using NP40 buffer with the protease inhibitor cocktail described above.  10% of each 
total extract was subjected to western blot analysis with mouse anti-Myc (1:2000 UNC 
Hybridoma) or mouse anti-HA (1:2000, UNC Hybridoma).  Secondary antibodies were ECL 
donkey anti-mouse HRP (1:10,000, GE Healthcare) and ECL donkey anti-rabbit HRP 
(1:10,000, GE Healthcare).  The remainder of the extract was incubated overnight at 4°C with 
0.5 µg mouse anti-Myc antibody (UNC Hybridoma) and 1/10 volume Protein G Sepharose 4 
Fast-Flow beads (GE Healthcare).  
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Results 
An in vivo assay for S phase-coupled E2f1 destruction 
In order to examine the biological functions of CRL4Cdt2-mediated destruction of E2f1 
during tissue growth and development, we examined larval wing imaginal discs, which grow 
from a ~50 cell primordium to a ~50,000 cell epithelial monolayer via canonical G1-S-G2-M 
cell division cycles and then differentiate into the adult wing during pupal development 
[17,35].  Imaginal disc growth is highly tuned to modulate the balance between proliferation 
and apoptosis in response to particular stimuli.  A dramatic example is the ability of wing 
discs to utilize “compensatory proliferation” in order to achieve normal wing development 
when as many as 50% of the disc cells have been killed via apoptosis following ionizing 
radiation [36].  This is possible because Drosophila apoptotic cells release mitogens such as 
Dpp and Wg that signal neighboring cells to begin proliferating and replace the dying cells 
[37,38,39].  We utilized this well characterized, rapidly proliferating tissue to examine the 
consequences of disrupting the normal S phase-coupled destruction of E2f1 (Figure 1A).  We 
sought to determine the extent to which this destruction contributes to the balance between 
proliferation and apoptosis. 
We previously established an assay for E2f1 destruction during S phase using flow 
cytometry of cultured Drosophila S2 cells expressing GFP-E2f1 fusion proteins [32].  In this 
assay, a mutation of E2f1 predicted to disrupt interaction with PCNA (GFP-E2f1PIP-3A) or a 
mutation predicted to abrogate CRL4Cdt2 binding (GFP-E2f1R161A) blocks S phase destruction 
(Figure S1A, B) [40].  We adapted this assay to wing imaginal discs in order to establish a 
quantifiable assay for measuring E2f1 destruction in vivo.  We used engrailed-Gal4 (en-Gal4) 
to induce GFP or GFP-E2f1 fusion protein expression (e.g. “en-Gal4 > GFP”) in all cells of 
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the posterior compartment of the disc (Figure S1C).  Wing discs were dissected from third 
instar larvae, dissociated into individual cells by trypsin digestion, and subjected to flow 
cytometry after staining cells with a DNA binding dye [41].  We were able to directly 
compare the cell cycle profile of GFP-expressing posterior compartment cells to GFP-
negative, anterior compartment control cells from the same tissue (Figure S1D-F).  Because 
GFP is stable throughout the cell cycle, all posterior compartment S phase cells from en-Gal4 
> GFP discs were also GFP-positive (Figure S1D, G).  In contrast, en-Gal4 > GFP-E2f1 
posterior compartment cells with an S phase DNA content were unlikely to be GFP-positive, 
because GFP-E2f1 is destroyed during S phase (Figure S1E, G).  Only ~12% of all GFP-E2f1 
expressing cells in the posterior compartment were also in S phase, whereas ~27% of GFP-
expressing cells were in S phase (Figure S1G).  This S phase destruction requires an intact PIP 
degron, as expression of GFP-E2f1PIP-3A resulted in an amount of GFP-positive posterior 
compartment S phase cells similar to GFP controls (Figure S1F, G).  (For the rest of this 
manuscript we will refer to stabilized E2f1PIP-3A as E2f1Stable).  These data extend our 
previously published wing disc experiments, in which we measured the effects of E2f1Stable 
expression on cell cycle progression by flow cytometry, but not directly on E2f1 destruction 
[32]. 
We previously showed that E2f1Stable expression accelerates cell cycle progression by 
using en-Gal4 to drive expression of GFP or GFP + GFP-E2f1 fusion proteins together in the 
posterior compartment of wing imaginal discs [32].  To measure such cell cycle effects for 
this study, we switched to co-expressing RFP with GFP or GFP-E2f1 fusion proteins (Figure 
S1C).  By determining the number of RFP-positive cells in each phase of the cell cycle via 
DNA content, we can obtain a cell cycle profile of all posterior compartment cells.  E2f1 
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stimulates cell cycle progression in wing imaginal disc cells by reducing the duration of G1 
phase [17].  Therefore, by comparing the number of RFP-positive cells with G1 DNA content 
after expression of GFP or GFP-E2f1, we are able to quantify the extent to which E2f1 
expression affects the cell cycle.  For example, expression of either GFP-E2f1 or GFP-
E2f1Stable caused a decrease in the percentage of cells in the population with a G1 DNA 
content compared to GFP expression alone (~11% versus ~28%, respectively; Figure S1H), 
indicating that both wild type and S phase-stabilized E2f1 proteins are equally able to increase 
the rate of wing disc cell cycle progression by reducing G1 length, as we previously described 
[32]. 
 
E2f1 domain mutations disrupt critical E2f1 functions 
We previously demonstrated that in addition to an increase in the rate of cell 
proliferation, ectopic expression of E2f1Stable in wing imaginal discs caused an increase in 
apoptosis [32].  Interestingly, under the conditions of these experiments, expression of wild 
type E2f1 did not induce apoptosis although it did increase the rate of proliferation.  We 
therefore hypothesize that E2f1Stable -induced apoptosis is not merely a consequence of 
increased cell proliferation resulting from excess E2f1 activity, but that the stabilization of 
E2f1 specifically in S phase triggers cell death. 
To explore this phenomenon further, we constructed variant forms of E2f1Stable in 
which key E2f1 activities--DNA binding, Rbf1 binding, and transactivation--were disrupted in 
order to determine those aspects of E2f1 function that are necessary for E2f1Stable -induced 
phenotypes (Figure 1B).  To disrupt DNA binding, we mutated to alanines four amino acids in 
the highly conserved RRXYD motif (R292, R293, Y295 and D296) that make direct contact 
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with bases in the E2F recognition sequence (E2f1DBD Mut) [42].  Mutation of the E2F RRXYD 
motif was previously demonstrated to block DNA binding [43].  To disrupt interaction with 
Rbf1, we engineered into our constructs a previously characterized missense mutation 
(L786Q) within the COOH-terminal Rbf1-binding domain of E2f1 that disrupts normal Rbf1-
E2f1 interaction but leaves E2f1 transactivation intact (E2f1Rb Mut) [44].  Because this single 
amino acid change does not completely eliminate Rbf1-E2f1 interaction (see Figure 2E), we 
also engineered into our constructs a previously described mutation (E2f1i2) that inserts a stop 
codon at amino acid Q527 [45].  This allele produces a truncated protein lacking the COOH 
terminal 1/3 of E2f1, thereby eliminating both transactivation function and Rbf1 binding.  We 
will refer to this allele as E2f1Trunc. 
We first determined whether the mutations we engineered affected GFP-E2f1 and 
GFP-E2f1Stable activity as predicted.  We generated UAS-transgenic lines and selected for 
analysis those that expressed equivalent amounts of GFP-E2f1 mRNA when driven with en-
Gal4 (Figure 1C).  Each GFP-E2f1Stable mutant protein accumulated to a similar level that was 
30-40% higher than either GFP-E2f1 or endogenous E2f1 (Figure 1D).  This increase in 
protein level is consistent with stabilization only during S phase, which represents about one 
third of the total cell cycle length (Figure 1F, GFP only). 
We next assessed the ability of the E2f1 mutant proteins to drive cell cycle progression 
and to activate E2f1 target gene expression.  The GFP-E2f1Rb Mut and GFP-E2f1Stable/Rb Mut 
Rbf1 binding mutants with intact transactivation domains were able to promote cell cycle 
progression (Figure 1E).  In contrast, expression of either GFP-E2f1 or GFP-E2f1Stable 
proteins with mutations that disrupt the transcriptional activity of E2f1, either by blocking 
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DNA binding (GFP-E2f1DBD Mut) or removing the transactivation domain (GFP-E2f1Trunc), 
failed to shorten G1 (Figure 1E).  Identical results were obtained using S2 cells (Figure S1I). 
 
Figure 3.1: Domain mutations disrupt critical E2f1 functionsA) Schematic of the experimental paradigm.  B) 
Schematic representation of E2f1 alleles used in this study.  C) qRT-PCR quantification of GFP-containing 
mRNA in en-Gal4 wing discs expressing GFP or the indicated GFP-E2f1 fusion proteins that lack (grey; “N”) or 
contain (black; “Y”) the PIP-3A mutation (Figure S1A) relative to a non-transgenic w1118 control (Con).  Error 
bars represent the standard error of three independent experiments.  These designations will be used throughout 
the remaining figures.  UAS-GFP expression was greater than any E2f1 construct because the UASt promoter 
was used rather than UASp.  D) Anti-E2f1 western blot measuring GFP-E2f1 and endogenous E2f1 expression 
in third instar imaginal wing discs.  The ratio of transgene expression to endogenous E2f1 expression is shown 
below.  E) Quantification by flow cytometry of RFP-positive G1 cells from trypsin-dissociated en-Gal4, UAS-
RFP wing discs expressing GFP or the indicated GFP-E2f1 fusion proteins.  * p< 0.001 as compared to GFP-
E2f1 expression.  F) qRT-PCR quantification of RnrS mRNA in en-Gal4 wing discs expressing GFP or the 
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indicated GFP-E2f1 fusion proteins.  G, H) Co-immunoprecipitation analysis of Myc-E2f1 and HA-Dp (G) or 
HA-Rbf1 (H) from transiently transfected S2 cells.  I) Quantification by flow cytometry of GFP-positive S phase 
cells from trypsin-dissociated en-Gal4 wing discs expressing GFP or the indicated GFP-E2f1 fusion proteins. * p 
< 0.001 compared between stabilized and normally degraded proteins.   
 
Mutations that disrupt DNA binding or transactivation should prevent E2f1 from 
activating expression of replication factor genes.  To test this prediction, we measured the 
level of RnrS mRNA, a well-known E2f1-regulated transcript [15].  While expression of GFP 
did not change the level of RnrS mRNA, both GFP-E2f1 and GFP-E2f1Stable expression 
resulted in a ~3 fold increase in RnrS mRNA in wing imaginal discs (Figure 1F).  Similar to 
the cell cycle progression results, those GFP-E2f1 or GFP-E2f1Stable mutant derivatives that 
are predicted to be deficient for E2f1 transcriptional activity (GFP-E2f1DBD Mut and GFP-
E2f1Trunc) were unable to induce RnrS expression, while the Rbf1 binding point mutant (GFP-
E2f1Rb Mut) induced RnrS expression similarly to GFP-E2f1 (Figure 1F).  Thus, the 
introduction of the S phase stabilizing mutation did not alter the transcriptional activity of 
E2f1. 
E2f1 requires dimerization with Dp for transcriptional activity and Rbf1 binding for 
normal regulation in G1 phase [46].  To determine whether our mutations affected Dp or Rbf1 
binding, we transiently transfected Myc-E2f1 with either HA-Dp or HA-Rbf1 into S2 cells 
and performed co-immunoprecipitation assays.  All of the E2f1Stable mutant proteins bound Dp 
equivalently to wild type E2f1 (Figure 1G).  Likewise, we found that E2f1, E2f1Stable, and 
E2f1Stable/DBD Mut precipitated similar amounts of Rbf1 (Figure 1H).  In contrast, E2f1Stable/Rb Mut 
precipitated a reduced amount of Rbf1 relative to E2f1, and the truncated E2f1Stable/Trunc 
showed no ability to precipitate Rbf1 (Figure 1H).  These data indicate that we have 
successfully created PIP degron mutant derivatives of E2f1 that have the predicted effects on 
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the ability to activate transcription and drive cell cycle progression (GFP-E2f1Stable/DBD Mut), 
bind Rbf1 (E2f1Stable/Rb Mut), or both (E2f1Stable/Trunc).  
 
E2f1 destruction does not require DNA binding or interaction with Rbf1 
We next asked whether any of these mutations affected S phase-coupled E2f1 
destruction.  Using either the wing disc or S2 cell flow cytometric assays, we found that 
E2f1DBD Mut, E2f1Rb Mut, and E2f1Trunc are each destroyed during S phase in a PIP degron-
dependent manner (Figure 1I, S1J) [32].  These data indicate that neither the DNA binding, 
Rbf1 interaction, or transactivation domains of E2f1 are required for S phase-coupled 
destruction.  We previously demonstrated that E2f1 destruction during S phase requires Dp 
[32], a result that could be interpreted as a requirement for E2f1/Dp DNA binding [34].  
However, an alternative interpretation from our observations that the E2f1DBD Mut protein 
binds Dp and is destroyed normally during S phase is that E2f1/Dp heterodimers are the 
preferred substrate of CRL4Cdt2.  In addition, these data suggest that a nuclear pool of E2f1/Dp 
that is not bound to DNA can interact with PCNA at replication forks and recruit the 
ubiquitylation machinery.   
 
Rbf1 binding but not DNA binding is required for S phase-stabilized E2f1 to induce 
apoptosis 
As we showed previously [32], GFP-E2f1Stable induces apoptosis in wing imaginal 
discs although expression of GFP-E2f1 or GFP does not (Figure 2A-C).  We hypothesized 
that some activity of E2f1 is necessary to cause cell death only when the protein is 
inappropriately stabilized in S phase.  To determine which functional domains of GFP-
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E2f1Stable were required to induce apoptosis, we expressed GFP-E2f1Stable variants containing 
each of the three mutations described above and stained wing imaginal discs with anti-cleaved 
caspase 3 antibodies (CC3).  We first examined the E2f1 DNA binding domain mutant.  As 
expected, GFP-E2f1DBD Mut, which does not function as a transcription factor or cell cycle 
regulator, did not induce apoptosis (Figure 2D).  Very surprisingly, however, we detected 
robust CC3 staining when this protein was stabilized during S phase with the PIP3A mutation 
(GFP-E2f1Stable/DBD Mut) (Figure 2E).  This result indicates that apoptosis in response to 
stabilizing E2f1 in S phase is neither a consequence of aberrant cell cycle progression or E2f1 
target gene expression, nor is it solely due to gross over-expression as the normally 
degradable E2f1DBD Mut did not cause this phenotype. 
We next addressed whether GFP-E2f1Stable-induced apoptosis requires an interaction 
with Rbf1.  Expression of GFP-E2f1Rb Mut did not induce apoptosis (Figure 2F).  The S phase-
stabilized Rbf1 binding mutant GFP-E2f1Stable/Rb Mut caused an increase in CC3 staining 
compared to controls, but less than we observed with either GFP-E2f1Stable or GFP-
E2f1Stable/DBD Mut expression (Figure 2G).  Intriguingly, this effect suggested that the ability of 
S phase-stabilized E2f1 to induce apoptosis requires an interaction with Rbf1 but not the 
ability of E2f to bind to E2F response elements at target genes or to shorten G1 phase.  To test 
the role of the E2f1-Rbf1 interaction further, we examined the C-terminally truncated GFP-
E2f1Stable/Trunc protein, which is devoid of Rbf1 binding.  Neither expression of the GFP-
E2f1Trunc nor the GFP-E2f1Stable/Trunc protein resulted in an increase in CC3 staining (Figure 
2H, I).  Importantly, both the GFP-E2f1Stable/Rb Mut and the GFP-E2f1Stable/Trunc proteins were 
expressed at levels equivalent to the GFP-E2f1Stable and GFP-E2f1Stable/DBD Mut proteins that 
induce apoptosis (Figure 1D).   
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Figure 3.2: E2f1Stable-induced apoptosis requires Rbf1 binding but not DNA binding  A-I) Detection of 
apoptosis via Cleaved Caspase-3 (CC3, red) staining of third instar larval wing imaginal discs expressing the 
indicated GFP-E2f1 (GFP, green) proteins with en-Gal4.  Arrow in D indicates an example of apoptosis observed 
in wild type wing discs. Bars = 50mM.  J) Quantification by flow cytometry of GFP-positive apoptotic cells from 
trypsin-dissociated en-Gal4 wing discs expressing GFP or the indicated GFP-E2f1 fusion proteins.  Error bars 
represent the standard error of three independent experiments.  ** p < 0.01, * p < 0.001.   
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To quantify the apoptosis induced by different GFP-E2f1 proteins, we measured the 
number of cells within a specific range of sub-G1 DNA content via flow cytometry of 
dissociated wing discs.  By this assay, we detected ~5% apoptotic cells in GFP-expressing 
control discs, which likely reflects both the normal low levels of apoptosis present in 
unperturbed discs (e.g. arrow Figure 2D) and the consequences of the extensive trypsinization 
required for dissociation (Figure 2J).  GFP-E2f1 caused only a slight increase in sub-G1 cells 
relative to GFP controls, as did the transcriptionally inactive GFP-E2f1DBD Mut (Figure 2J).  In 
contrast, and in correspondence with the CC3 staining of intact discs, expression of GFP-
E2f1Stable or GFP-E2f1Stable/DBD Mut, which lacks a functional DNA binding domain, caused a 
significant increase in the apoptotic population of cells relative to controls (Figure 2J).  The 
E2f1Stable/Rb Mut Rbf1-binding mutant triggered apoptosis, but less so than GFP-E2f1 proteins 
with a wild type Rbf1 binding domain, and the GFP-E2f1Stable/Trunc Rbf1-binding deficient 
mutant did not significantly increase apoptosis above controls (Figure 2J).  These data 
indicate that interaction with Rbf1 is required for S phase-stabilized E2f1 to induce apoptosis.  
They also suggest that cells have a mechanism to detect aberrant E2f1 protein levels during S 
phase that is independent of E2f1’s role as a transcription factor.  
 
E2f1Stable causes defects in the first cell cycle after induction of its expression 
Our experiments thus far utilize en-Gal4 to drive GFP-E2f1 expression continuously in 
the posterior compartment during growth of the wing imaginal disc. Because this expression 
initiates very early during development, we cannot determine whether phenotypes arise in the 
very first cell cycle after stabilizing E2f1 during S phase, or result from E2f1Stable expression 
over many cell cycles.  To address this issue, we took advantage of the distinct cell cycle 
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program of eye imaginal discs.  During third instar larval development, a wave of 
differentiation associated with a coordinated cell shape change called the morphogenetic 
furrow (MF) sweeps across the eye disc from posterior to anterior over a period of two days 
[47].  Cells anterior to the MF are undifferentiated and undergo asynchronous cell 
proliferation, while cells posterior to the MF differentiate into the neurons and other 
specialized cell types of the compound eye.  Cells within the MF arrest in G1 phase, and as 
they exit the MF some cells remain in G1 and differentiate while others synchronously reenter 
a final cell division cycle prior to terminal differentiation called the “second mitotic wave” 
(SMW) (Figure 3A) [48]. 
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Figure 3.3:  E2f1Stable acts acutely to trigger apoptosis  A-E) Detection of S phase by EdU labeling (red) and 
apoptosis by CC3 staining (green) in GMR-Gal4 third instar larval eye imaginal discs expressing GFP or the 
indicated GFP-E2f1 fusion proteins.  Arrowheads indicate the position of the MF, with anterior to the left and 
posterior to the right.  Bars = 5mM.  F) Quantification of the number of CC3 positive cells posterior to the MF.  * 
p < 0.001 relative to UAS-E2f1 expression. 
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The GMR-Gal4 driver is activated in late G1 cells of the MF and remains on in all 
cells posterior to the MF (Figure S2A).  By using GMR-Gal4 we could examine the very first 
cell cycle after expression of the E2f1 transgenes.  Normal eye discs have a very organized 
and stereotypical pattern of S phase in the SMW, and very few cells enter apoptosis 
immediately posterior to the MF (Figure 3A).  Expression of GFP-E2f1 resulted in minimal 
changes to S phase of the SMW and no significant increase in apoptosis posterior to the MF 
(Figure 3B, F).  (Note that others have demonstrated previously that co-expression of E2f1 
and Dp with GMR results in ectopic S phase in the MF and apoptosis [21].)  In contrast, 
expression of E2f1Stable disrupted the normal S phase pattern:  we observed an increase in the 
number of cells entering S phase as well as an expansion of the zone of EdU labeling posterior 
to the MF, suggesting an increase in the length of S phase (Figure 3C).  The changes in the S 
phase pattern caused by GFP-E2f1Stable were accompanied by an increase in DNA damage, as 
measured by anti-phospho-H2Av staining (Figure 4A-C, F), and apoptosis posterior to the MF 
(Figure 3C, F).  There was no change in the number of cells entering mitosis posterior to the 
MF, as measured by anti-phospho-histone H3 staining (Figure S2B), suggesting that cells die 
before entering mitosis.  In addition, E2f1Stable did not induce apoptosis when expressed in 
G1-arrested epidermal cells in the embryo (Figure S3), suggesting that apoptosis may be S 
phase specific.  These data suggest that the presence of stabilized E2f1 in even a single S 
phase can disrupt cell cycle progression, induce DNA damage, and result in apoptosis.  
Importantly, however, DNA damage and apoptosis does not occur in all of the cells 
expressing E2f1Stable, much like we observed by flow cytometry in the wing discs (Figure 2J).  
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Figure 3.4:  E2f1Stable causes DNA damage  A-E) Detection of DNA damage by anti-phospho-H2Av staining 
(red) in GMR-Gal4 third instar larval eye imaginal discs expressing GFP or the indicated GFP-E2f1 fusion 
proteins (green).  Arrowheads indicate the position of the MF, with anterior to the bottom and posterior to the 
top.  Bars = 10mM.  F) Quantification of the number of phospho-H2Av positive cells posterior to the MF. * p < 
0.001 relative to UAS-E2f1 expression. 
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E2f1Stable induces apoptosis in two ways in eye discs 
We next asked whether the DNA damage and apoptosis observed after S phase 
stabilization of E2f1 resulted from aberrant cell cycle progression.  Expression of GFP-
E2f1Stable/DBD Mut did not perturb the organization of S phase in the SMW (Figure 3D) or result 
in an increased number of phospho-H2Av foci (Figure 4D, F), likely because this protein does 
not alter cell cycle progression.  Thus, the DNA damage observed with E2f1Stable was most 
likely due to proliferation defects, because mutants that failed to shorten G1 did not induce 
phospho-H2Av.  On the other hand, when compared to controls, GFP-E2f1Stable/DBD Mut 
expression did not cause an increase in phospho-H2Av foci (Figure 4D, F), although it still 
resulted in an increase in apoptosis posterior to the MF Figure 3D, F).  These data suggest that 
stabilizing E2f1 in S phase can trigger apoptosis independently of cell cycle effects.  The level 
of apoptosis in GMR > GFP-E2f1Stable/DBD Mut discs was somewhat less than in GMR > GFP-
E2f1Stable discs, suggesting a contribution from proliferative stress that is dependent on E2f1 
DNA binding (Figure 3F).  As in wing discs, apoptosis required an interaction with Rbf1 
because GFP-E2f1Stable/Rb Mut expression resulted in reduced apoptosis compared to GFP-
E2f1Stable (Figure 3E, F).  Taken together, these data suggest that two factors contribute to 
apoptosis when E2f1 is stabilized in S phase in the SMW:  proliferative stress caused by 
aberrant E2f1 activity that leads to DNA damage, and a mechanism independent of E2f1 DNA 
binding activity that relies on interaction with Rbf1. 
We previously reported that E2f1Stable expression in the posterior compartment of the 
wing discs did not increase the amount of detectable DNA damage [32].  Our eye discs results 
prompted us to reexamine this issue.  Using a different source of anti-phospho-H2Av 
antibody, we detected an increase in phospho-H2Av foci in wing imaginal discs following 
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expression of GFP-E2f1Stable, and as in the eye discs this amount was more than with GFP-
E2f1 expression (Figure S4).  
 
Apoptosis requires full length E2f1Stable 
 Our data are consistent with the hypothesis that an interaction between S phase-
stabilized E2f1 and Rbf1 triggers apoptosis, even when E2f1Stable cannot bind DNA and is 
functionally inactive as a transcription factor.  This result suggests that cells can specifically 
detect and respond to E2f1/Rbf1 complexes that inappropriately assemble in S phase.   
However, another possibility is that over-expression of any Rbf1 binding protein would 
trigger apoptosis.  To distinguish between these possibilities, we utilized a NH2-terminally 
truncated allele of E2f1 (E2f1336-805) that we previously characterized [49].  E2f1336-805 
contains only the C-terminal half of the E2f1 protein, and thus lacks the PIP degron and DNA 
binding domain but retains the Rbf1 binding and transactivation domains (Figure 5A).  We 
hypothesized that this protein would interact with Rbf1 during S phase, but not trigger 
apoptosis because of the absence of a domain necessary for cells to detect the E2f1Stable/Rbf1 
complex.  Indeed, en-Gal4 expression of E2f1336-805 failed to induce apoptosis (Figure 5B), 
even though this protein accumulated to levels similar to GFP-E2f1Stable (Figure 5C) and 
efficiently interacted with Rbf1 in co-immunoprecipitation assays (Figure 5D).  These data 
indicate that interaction with Rbf1 is not by itself sufficient to induce apoptosis, and suggest 
that full-length E2f1Stable is specifically recognized by cells to induce apoptosis.  
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Figure 3.5:  Induction of Apoptosis requires full length E2f1Stable A) Schematic of the E2f1336-805 mutant 
protein, which contains an NH2-terminal HA tag. B) Detection of apoptosis via Cleaved Caspase-3 (CC3, red) 
staining of third instar larval wing imaginal discs expressing HA-E2f1336-805 (anti-HA, green) with en-Gal4.  Bar 
= 50 µm.  C) Anti-E2f1 western blot of third instar imaginal wing discs expressing GFP-E2f1, GFP-E2f1Stable, or 
HA-E2f1336-805.  D) Co-immunoprecipitation analysis of Myc-E2f1 and HA-Rbf1 from transiently transfected S2 
cells.  
 
Stabilizing E2f1 during S phase causes apoptosis by inducing hid expression  
What mechanism could explain the induction of apoptosis upon stabilization of a 
transcriptionally inert, but Rbf1 binding-proficient, E2f1 protein during S phase?  Recent 
work from several laboratories showed that loss of Rbf1 function causes apoptosis in several 
developmental contexts by triggering expression of the pro-apoptotic gene, hid 
[18,24,25,50,51].  Hid is homologous to SMAC/Diablo family proteins that function to 
antagonize IAPs, which act to block activator caspases.  hid expression triggers an apoptotic 
cascade by antagonizing DIAP1, thus releasing inhibition of the initiator caspase Dronc and 
activating the effector caspase Drice [36,52]. 
We hypothesized that GFP-E2f1Stable or GFP-E2f1Stable/DBD Mut binds to Rbf1 and 
disrupts its function, resulting in activation of hid expression.  This hypothesis predicts that 
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GFP-E2f1Stable or GFP-E2f1Stable/DBD Mut expression will increase hid expression, while E2f1 
mutants that cannot bind Rbf1 will fail to increase expression.  To test this prediction, we used 
qRT-PCR to measure the levels of hid mRNA in wing imaginal discs expressing the various 
GFP-E2f1 transgenes with en-Gal4.  Consistent with our hypothesis, there was a two-fold 
increase in hid mRNA in GFP-E2f1Stable- or GFP-E2f1Stable/DBD Mut -expressing discs relative to 
those expressing GFP-E2f1 or GFP-E2f1DBD Mut (Figure 6A).  Similar levels of hid induction 
were previously observed following ionizing radiation treatments that trigger apoptosis [24].  
hid expression was not significantly increased by the GFP-E2f1 mutants lacking normal Rbf1 
binding activity (Figure 6A).  To test whether the hid de-repression was a specific response to 
stabilizing E2f1 in S phase, we measured expression of another pro-apoptotic gene, reaper, 
which is not de-repressed by Rbf1 mutation [24].  We detected no increase in reaper mRNA 
in discs expressing any GFP-E2f1 transgene (Figure 6B). 
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Figure 3.6: Stabilizing E2f1 during S phase induces hid expression  A, B) qRT-PCR quantification of hid 
mRNA (A) or rpr mRNA (B) in en-Gal4 wing discs expressing GFP or the indicated GFP-E2f1 fusion proteins 
that lack (grey) or contain (black) the PIP3A mutation relative to a non-transgenic w1118 control (Con). * p < 
0.001.  C-I) Detection of apoptosis via Cleaved Caspase-3 (CC3, red) staining of third instar larval wing imaginal 
discs expressing the indicated GFP-E2f1 (GFP, green) proteins with en-Gal4.  En-Gal4 > E2f1Stable (C-E) or 
E2f1Stable/DBD (F-H) in either a wildtype hid background (+/+), or heterozygous Hid05141/+ or Df(3L)H99/+ 
backgrounds.  I) Quantification of CC3 pixel intensity as measured using ImageJ.  All genotypes were 
normalized against E2f1Stable; +/+ cleaved caspase-3 levels.  * p < 0.001.  n.s. not significant. n=12 discs for each 
genotype.  
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To test if hid expression contributed to E2f1Stable-induced apoptosis, we determined 
whether reducing hid gene dose would result in a decrease in apoptosis.  We utilized two 
different hid alleles: hid05014, containing a transposable element insertion between amino acids 
105 and 106 in the open reading frame that effectively reduces hid expression [53], and 
Df(3L)H99, which deletes the entire hid gene as well as the neighboring pro-apoptotic genes, 
reaper and grim [53,54].  Wing discs heterozygous for either hid allele contained a 
significantly reduced amount of apoptosis after GFP-E2f1Stable or GFP-E2f1Stable/DBD 
expression compared to controls (Figure 6C-H, I).  Quantification of CC3 staining revealed no 
significant difference between the results obtained with hid05014 (Figure 6D, G, I) and 
Df(3L)H99 (Figure 6E, H, I).  This result suggests that grim and reaper do not contribute as 
substantially as hid to E2f1Stable-induced apoptosis, consistent with our failure to detect an 
increase in reaper expression by E2f1Stable and its derivatives (Figure 6B).  These data support 
the idea that stabilizing E2f1 during S phase results in disruption of Rbf1 function leading to 
de-repression of hid expression and apoptosis. 
 
E2f1Stable induces hypertrophy when cells are prevented from executing apoptosis 
Why would Drosophila cells induce a potent activator of apoptosis in response to 
elevated E2f1 protein levels during S phase?  We considered the possibility that a small 
number of individual cells in a growing population of adult precursor cells, like those in wing 
imaginal discs, might stochastically experience hyper-expression of E2F that would manifest 
as the presence of excess E2f1 protein in S phase.  Such cells would be eliminated by 
apoptosis, thereby helping to maintain growth homeostasis by suppressing the appearance of 
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potentially hyperplastic cells that could lead to aberrant overgrowth.  If this was a 
developmentally important event, then blocking the ability of tissues to eliminate such cells 
by apoptosis should disrupt normal development.   
To test this idea, we used en-Gal4 to co-express GFP-E2f1 transgenes in wing 
imaginal discs together with baculovirus p35, which efficiently blocks apoptosis in 
Drosophila cells [55].  Expressing p35 together with GFP had no deleterious effects on wing 
disc development (Figure 7A).  In contrast, GFP-E2f1/p35 co-expression resulted in a range 
of morphological defects caused by hyperplastic growth.  While some GFP-E2f1/p35-
expressing discs appeared normal, most displayed various degrees of overgrowth in the 
posterior portion of the disc (Figure 7B).  We quantified this overgrowth by microscopically 
measuring posterior compartment “thickness”, which we defined as the sum of the number of 
confocal sections one micron apart required to image through the entire posterior 
compartment.  Using this measurement we binned the discs into four phenotypic categories:  
normal (<9 µm), mild (9-11 µm), moderate (12-15 µm), and severe (>15 µm) (Figure 7D).  
GFP-E2f1Stable/p35 expression caused a more severe phenotype than did GFP-E2f1/p35 
expression.  None of the discs were normal, and a larger percentage of the discs fell into the 
severe overgrowth category (Figure 7C, D).  In addition, GFP-E2f1Stable/p35 expression 
caused the appearance of a unique fifth phenotype in ~1/3 of the discs, which we called 
“arrest” (Figure 7C, D).  In these discs the posterior compartment was almost absent, as 
confirmed by co-expression of RFP.  We speculate on the origin of this class of discs in the 
Discussion.  Expression of p35 together with either GFP-E2f1 or GFP-E2f1Stable caused 100% 
lethality.  Importantly, the hyperplastic growth induced by GFP-E2f1 or GFP-E2f1Stable 
required the normal transcriptional and cell cycle-promoting activity of E2f1, as co-expression 
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of p35 with GFP-E2f1DBD Mut or GFP-E2f1Stable/DBD Mut resulted primarily in normal wing discs 
and did not cause lethality (Figure 7D).  These data indicate that the developmental effects of 
E2f1 hyper-activity during tissue growth are exacerbated by simultaneously blocking 
apoptosis and E2f1 destruction in S phase.    
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Figure 3.7:  E2f1Stable causes homeostasis defects and tissue hyperplasia  A-C) Detection of GFP or the 
indicated GFP-E2f1 proteins (green) in en-Gal4, UAS-p35 wing discs stained with DAPI (white).  Scale bars 
indicate 50 µm.  D) Quantification of morphological defects by microscopically measuring the thickness of the 
posterior compartment of the indicated en-Gal4 > GFP-E2f1 wing discs.  Measurements were obtained by 
counting the number of 1 micron sections required to visualize all the way through the posterior compartment of 
the tissue.  Bars = 50mM.  E) E2f1Stable induces apoptosis in two ways. 
 
DISCUSSION 
We show here that stabilizing the single Drosophila activator E2f1 in S phase results 
in apoptosis that is necessary to prevent hypertrophy of wing imaginal discs.  We conclude 
from these data that hyper-accumulation of E2f1 during S phase represents a form of 
proliferative stress during development that is sensed by the apoptotic machinery and results 
in the elimination of cells with excess E2f1 activity to maintain homeostasis during tissue 
growth. 
 
S phase-coupled E2f1 destruction helps balance cell proliferation with apoptosis  
What might be the function of a Drosophila cell’s ability to detect abnormal 
accumulation of E2f1 protein during S phase and subsequently trigger apoptosis?  One 
possibility is that accumulation of E2f1 during S phase resembles instances of abnormally 
high E2f1 activity that might occur sporadically during rapid growth of a population of 
precursor cells such as those in the wing imaginal disc.  These events could be caused by 
stochastic or even genetic changes that affect either E2f1 gene transcription or the ability of 
the CRL4Cdt2/PCNA pathway to destroy E2f1 after replication factor genes are activated in 
late G1.  The cell’s ability to detect E2f1 accumulation in S phase clears these potentially 
hyperplastic cells from developing tissues via apoptosis, consequently contributing to the 
balance between cell proliferation and cell death that is necessary for normal tissue growth.  
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Growing Drosophila imaginal discs possess another mechanism of homeostasis in 
which a process of compensatory proliferation is activated in order to achieve normal tissue 
development when as many as 50% of cells are killed by external stimuli like radiation-
induced DNA damage [56].  Indeed, in spite of high levels of apoptosis (15% of the cells), 
50% of en-Gal4 > E2f1Stable progeny survive until adulthood with about 2/3 of these surviving 
flies containing wings with somewhat mild morphological defects [32].  Blocking apoptosis 
with baculovirus p35 when E2f1Stable is expressed shifts the cell proliferation/apoptosis 
balance too strongly in favor of cell proliferation, resulting in massive hypertrophy and 100% 
lethality. 
p35 is a broad caspase inhibitor that blocks effector caspase activity at a step 
downstream of their proteolytic activation [55].  Therefore, cells expressing p35 can initiate 
apoptosis, but lack the capacity to complete it and are referred to as “undead cells.”  These 
undead cells produce signals that stimulate unaffected neighboring cells to proliferate [36].  
Thus, the dramatic hypertrophy we see in E2f1Stable/p35 wing discs might be the result of two 
synergizing growth signals:  hyper-active E2f1 and compensatory proliferation from undead 
cells.  Our experiments cannot precisely discern the relative contribution of these two inputs, 
but E2f1 activity appears to make a larger contribution because E2f1Stable/DBD Mut expression 
does not cause dramatic overgrowth. 
 What might explain the 32% of en-Gal4 > E2f1Stable discs that displayed a reduced 
posterior compartment rather than an overgrown one:  the “arrest” phenotype in Fig 7?  The 
DNA damage we observed in our eye discs experiments provides a possible answer.  Perhaps 
early in development the “arrest” class of wing discs sustained enough genomic damage to 
prevent proliferation, resulting in too small a pool of cells that could respond to the hyper-
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active E2f1 and undead cell signals to support disc overgrowth.  Thus, the wide range of 
phenotypes that we observed in E2f1Stable/p35 wing discs may result from multiple influences 
that act stochastically within the population (Figure 7E).  
 
A cellular sensor of E2f1 hyper-accumulation 
Because endogenous E2f1 is quantitatively destroyed only in S phase, the relative 
amount of hyper-accumulation of E2f1Stable is greater during S phase than during any other 
stage of the cell cycle.  Therefore, one possibility is that E2f1Stable-induced phenotypes result 
from the stability of E2f1 protein in S phase, and not from general over-expression throughout 
the cell cycle.  Our failure to detect E2f1Stable induced apoptosis in G1-arrested embryonic 
cells is consistent with this possibility.  However, another difference between these embryonic 
cells and wing discs cells is that the former are cell cycle arrested and the latter are 
continuingly proliferating during larval development.  Thus, another possibility is that S 
phase-destruction of E2f1 modulates the levels of E2f1 in proliferating cells, and cells that fail 
to destroy E2f1 during S phase have an increased chance of activating apoptosis at any point 
in the cell cycle.  In either model, S phase E2f1 destruction is not essential for proliferation 
per se.  In marked contrast, E2f1Stable expression blocks endocycle progression [57], 
suggesting that knocking in E2f1Stable to the endogenous locus would be lethal during 
development, perhaps even dominant lethal. 
E2f1Stable induces apoptosis at least in part through expression of the pro-apoptotic 
gene hid.  Surprisingly, these events still occur after expression of an E2f1Stable variant that 
cannot bind DNA and therefore lacks the ability to stimulate transcription of replication factor 
genes or cell cycle progression.  Instead, E2f1Stable requires the ability to bind Rbf1 to induce 
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hid gene expression and apoptosis.  Genetic disruption of Rbf1 is well known to result in 
increased hid expression [18,25,51].  We therefore propose that the inappropriate 
accumulation of E2f1 in S phase disrupts some aspect of Rbf1 function leading to hid 
expression and apoptosis. 
Our data do not discern either the function of Rbf1 that is disrupted by E2f1Stable or the 
mechanism of hid induction.  While the mechanism connecting Rbf1/E2f1 function and hid 
may be indirect, some studies suggest that Rbf1 and/or E2f1 could regulate hid directly.  Su 
and colleagues recently demonstrated that Drosophila wing disc cells undergo apoptosis in 
response to ionizing radiation independently of p53 and that this response requires E2f1 and is 
triggered by hid expression [26].  In eye discs, loss of Rbf1 function in the MF results in 
apoptosis that requires E2f1 transactivation function and is accompanied by hid expression 
[18,50].  However, whether these effects represent a direct induction of hid by E2f1 is not 
clear.  E2f1 binding at the hid locus has been observed, but the binding site is located ~1.4 kb 
upstream of the of the start of hid transcription, which is more distal than in well characterized 
E2F-regulated promoters [58].  When located this far upstream the hid E2f1 binding site fails 
to activate gene expression in S2 cell reporter assays [25].  hid is also a target of p53 [59], and 
so any DNA damage resulting from stabilizing E2f1 during S phase, as we observed in eye 
discs, may also contribute to the activation of hid expression via p53-mediated DNA damage 
response pathways. 
Another possibility is that E2f1, in combination with Rbf1, plays primarily a 
repressive role at the hid locus.  In this model, our result that E2f1Stable or E2f1Stable/DBD Mut 
both induce apoptosis would be explained by disruption of Rbf1/E2f1 repressive complexes at 
the hid locus causing de-repression of hid expression.  This model has interesting caveats:  
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what protects the Rbf1/E2f1 complex at the hid locus from being disrupted by Cyclin E/Cdk2, 
which is active during S phase and inactivates Rbf1-mediated repression of E2f1 [60], or by 
CRL4Cdt2-mediate destruction of E2f1?  Recent data indicate that the dREAM/MMB complex 
is required for the stability of E2F/Rbf1 repressive complexes in S phase, and acts to protect 
these complexes from CDK-mediated phosphorylation at non-cell cycle-regulated genes [61].  
While there is yet no evidence that dREAM/MMB regulates hid [62], this work provides 
precedent for gene specific Rbf1 regulation during S phase. 
Finally, while hid might be a critical player in the response to E2f1Stable, there are 
likely other mechanisms responsible for sensing and modulating the apoptotic response to 
E2f1 levels.  For instance, Frolov and colleagues recently demonstrated that a micro-RNA, 
mir-11, which is located within the last intron of the Drosophila E2f1 gene, acts to dampen 
expression of pro-apoptotic E2f1 target genes following DNA damage [28].  In this way, the 
normal controls of E2f1 gene expression modulate apoptosis.  In addition, our transgenic 
constructs lack the normal E2f1 3’ UTR, which serves as a site for suppression of E2f1 
expression by pumilio translational repressor complexes [63].  Thus, we have bypassed 
several modes of E2f1 regulation via transgenic expression of E2f1Stable. 
 
Conservation of E2F regulation via different molecular mechanisms 
Our finding that stabilized Drosophila E2f1 can induce apoptosis independently of 
transcription and cell cycle progression parallels previous observations made in mammalian 
cells, albeit with important differences.  In mammalian cells, E2F1 can induce apoptosis 
independently of transcription and cell cycle progression, but apoptosis required E2F1 DNA 
binding activity, unlike in our experiments [64,65].  These studies suggested that DNA 
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binding by E2F1 prevented pro-apoptotic promoters from binding repressor E2F family 
members. 
This comparison of results highlights the way similar phenotypic outcomes in different 
species can arise from different mechanisms.  While mammalian activator E2Fs are also 
inhibited during S phase, they are not subject to CRL4Cdt2-mediated, S phase-coupled 
destruction like Drosophila E2f1.  Instead, mammalian activator E2Fs are inhibited by direct 
Cyclin A/Cdk2 phosphorylation [6,7,8], targeted for destruction by SCFSkp2 [9,10], and 
functionally antagonized by E2F7 and E2F8 [11,12].  The regulation provided by E2F7 and 
E2F8 is of particular note, as it is essential for mouse development [11].  These atypical E2Fs 
homo and hetero-dimerize and act redundantly to repress E2F1 target genes independently of 
pRb family proteins, thus blocking E2F1 from inducing apoptosis [11].  Moreover, the E2F7 
and E2F8 genes are E2F1 targets [11], consequently creating a negative feedback loop that 
limits E2F1 activity after the G1/S transition.  A similar negative feedback loop among factors 
that regulate G1/S transcription exists in yeast [66].  The analogous Drosophila negative 
feedback loop involves E2f1 inducing its own destruction by stimulating Cyclin E 
transcription, which triggers S phase [60].  Therefore, the evolution of eukaryotes has resulted 
in the use of different molecular mechanism to achieve negative feedback regulation of G1/S-
regulated transcription, and in the case of activator E2Fs this regulation is essential for normal 
development.  
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SUPPLEMENTAL FIGURES 
 
Figure S1:  An in vivo assay for S phase-coupled E2f1 destruction  A) Alignment of PIP degrons from known 
CLR4Cdt2 substrates.  Amino acids of the PIP box are bold and those of Cdt1 that interact with Cdt2 are 
underlined.  E2f1 contains a PIP box located at amino acids 150-157.  E2f1 also contains a basic Arg residue 
(R161) four amino acids downstream of the PIP box, much like the basic K+4 residue found in the Cdt1 PIP 
degron.  Amino acid changes in E2f1PIP-3A and E2f1R161A mutants, which contain nonfunctional PIP degrons, are 
shown at the bottom.  B) An S2 cell flow cytometry assay to quantify the number of GFP-positive cells that are 
in S phase.  The graph indicates the percentage of GFP-positive S2 cells in S phase 200 min after heat shock 
expression of GFP, GFP-E2f1, GFP-E2f1R161A or GFP-E2f1PIP-3A.  After induction of GFP, all S phase cells in the 
population are GFP-positive (~25%) because GFP protein is stable throughout the S2 cell cycle.  In contrast, 
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after induction of GFP-E2f1 expression, only ~10% of GFP-positive cells are in S phase because GFP-E2f1 is 
targeted by CRL4Cdt2 for S phase destruction.  The amount of GFP-positive cells in S phase after induction of 
GFP-E2f1PIP3A or GFP-E2f1R161A is equivalent to the amount after GFP induction, indicating that Drosophila 
E2f1 requires both a PIP box and a basic Arg residue 4 amino acids downstream of the PIP box for destruction 
during S phase.  Here and in subsequent panels * indicates p < 0.001 and error bars represent the standard error 
of at least three independent experiments.  C) Third instar larval imaginal wing disc expressing RFP and GFP 
with en-Gal4.  D-F) Flow cytometry profile of GFP expression versus DNA content from en-Gal4 > GFP (D) en-
Gal4 > GFP-E2f1 (E) or en-GAL4 > GFP-E2f1Stable (F) trypsin-dissociated third instar imaginal wing disc cells.  
For each profile, data were acquired until 10,000 total cells were detected.  The red boxes illustrate a 
representation of the S phase cells, and the blue dotted lines indicate the threshold for categorizing a cell as GFP 
positive (based on GFP negative control).  Note that GFP expression (D) was higher than GFP-E2f1 or GFP-
E2f1Stable expression because the UASt promoter was used rather than UASp.  G) Quantification by flow 
cytometry of GFP-positive S phase cells from trypsin-dissociated en-Gal4 > GFP, GFP-E2f1, or GFP-E2f1Stable 
wing discs.  H) Quantification by flow cytometry of RFP-positive G1 phase cells from trypsin-dissociated, en-
Gal4 wing discs expressing GFP or the indicated GFP-E2f1 fusion proteins.  I) Quantification by flow cytometry 
of GFP-positive S2 cells in G1 phase after transient transfection of Actin5C promoter-driven constructs 
containing GFP or the indicated GFP-E2f1 fusion proteins that lack (grey) or contain (black) the PIP-3A 
mutation.  J) Quantification by flow cytometry of GFP-positive S2 cells in S phase 200 min after heat shock 
expression of indicated GFP-E2f1 constructs that lack (grey) or contain (black) the PIP-3A mutation. 
 
 
Figure S2:  GMR-Gal4 > GFP-E2F1 eye discs stained with anti-PH3  A) GMR > UAS-GFP eye disc.  White 
box indicates example of areas shown in panel B and in Figure 3.  Yellow box indicates areas shown in Figure 4.  
B) Detection of mitosis by anti-phospho histone H3 staining (red) of GMR-Gal4 third instar larval eye imaginal 
discs expressing GFP or the indicated GFP-E2f1 fusion proteins (green).  Arrowheads indicate the position of the 
MF, with anterior to the left and posterior to the right.  Bars = 5mM. 
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Figure S3:  E2f1Stable does not induce apoptosis in G1 arrested embryonic cells.  A-D) Stage 11 embryos (9-
11 hours post egg laying) expressing GFP or the indicated GFP-E2f1 fusion proteins with en-Gal4.  Green: GFP 
for transgene expression, Red: Cleaved Caspase-3, White: phospho-tyrosine for cell membrane marker, Blue: 
DAPI for nuclei).  Epithelial cells (white) on the surface of the embryo have exited the cell cycle and are arrested 
in G1.  E) En-Gal4 > UAS-GFP embryo with a CC3-positive apoptotic cell (red) below the surface epithelial 
cells.  This cell is most likely a neuronal cell and is shown as a positive control for CC3 detection.  F) En-Gal4 > 
UAS-reaper embryo shown to ensure that the epidermal cells respond to pro-apoptotic signals and accumulate 
CC3. Bars = 10mm.  
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Figure S4:  E2f1Stable induces DNA damage in wing discs.  A-C) Detection of DNA damage by anti-phospho-
H2Av staining (red) in en-Gal4 third instar larval eye imaginal discs expressing GFP or the indicated GFP-E2f1 
fusion proteins (green).  E) Quantification of anti-phospho-H2Av staining.  Foci above a calibrated threshold 
(ImageJ) were counted for each allele.  n=10 discs for each genotype.  Both E2f1 alleles had significantly more 
foci than UAS-GFP alone (* = p < 0.001).  
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CHAPTER IV 
ATYPICAL CELL CYCLES DURING DEVELOPMENT 
 
 
PREFACE 
 This work was previously published as review article in Genes & Development in 2009.  
It was written by a former graduate student, Kate Lee, and myself, while Robert Duronio 
conceived the project and finalized the manuscript.  
 Lee, HO., Davidson, JM., and Duronio, R.J. (2009). Endoreplication: Polyploidy 
with Purpose.  Genes & Development, 23 (21): 2461.   
 
 
ABSTRACT 
A great many cell types are necessary for the myriad capabilities of complex, multi-
cellular organisms. One interesting aspect of this diversity of cell type is that many cells in 
diploid organisms are polyploid.  This is called endopolyploidy and arises from cell cycles 
that are often characterized as “variant”, but in fact are widespread throughout nature.  
Endopolyploidy is essential for normal development and physiology in many different 
organisms.  Here we review how both plants and animals use variations of the cell cycle, 
termed collectively as endoreplication, resulting in polyploid cells to support specific aspects 
of development.  In addition, we briefly discuss how endoreplication occurs in response to 
certain physiological stresses, and how it may contribute to the development of cancer. 
Finally, we describe the molecular mechanisms that support the onset and progression of 
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endoreplication. 
 
ENDOREPLICATION BIOLOGY, CONSERVATION AND SIGNIFICANCE  
Definition of endoreplication 
           Endopolyploidy arises from variations of the canonical G1-S-G2-M cell division cycle 
that replicate the genome without cell division.  In this review, we use endoreplication as a 
general term encompassing any type of cell cycle leading to endopolyploidy.  One 
widespread form of endoreplication is the developmentally controlled endocycle, which 
consists of discrete periods of S phase and G phase resulting in cells with a single polyploid 
nucleus (Edgar and Orr-Weaver, 2001; Lilly and Duronio, 2005).  A key feature of the 
endocycle is that DNA content increases by clearly delineated genome doublings (Fig. 4.1A).   
  
Figure 4.1: Endoreplication.  A) Endocycles are defined by controlled cycles of S and G phase without cell 
division.  Endocycling cells do not eneter mitosis, and thus do not exhibit features of mitosis such as condensed 
chromosomes and nuclear envelope breakdown.  Trichomes  arise from polyploid cells that can be found of the 
surface of a variety of plant tissues. B) Re-replication results from aberrant regulation in which DNA synthesis 
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is initiated multiple times at individual origins of replication within a single S phase. This results in an indistinct 
DNA content as depicted by black lines in this hypothetical FACS profile (y axis is cell number and x axis is 
DNA content).  Green represents the diploid mitotic cell profile, with 2C and 4C peaks.  Blue represents 
endoreplication cycles that result in distinct populations of cells with more than 4C DNA content.  C) During 
endomitosis, cells enter mitosis and begin to condense chromosomes, but do not segregate chromosomes to 
daughters.  Instead, they enter a G1 like state and re-enter S phase.  Megakaryocytes use endomitosis upon 
maturation, leading to a globulated nuclear structure.  Blood clot-promoting thrombocytes (or platelets) bud off 
of the polyploidy megakaryocytes.  
This is an important distinction from the aberrant process of re-replication, which is 
characterized by uncontrolled, continuous re-initiation of DNA synthesis within a given S 
phase resulting in increases in DNA content without clearly recognizable genome doublings 
(Blow and Hodgson, 2002; Zhong et al., 2003).  Re-replication results from perturbations to 
the molecular mechanisms that control the “once and only once” firing of replication origins 
during a normal diploid S phase, and is thought to be a source of genome instability that 
contributes to oncogenic transformation (Fig. 4.1B).   
Another major form of endoreplication occurs through the process of endomitosis in 
which cells enter but do not complete mitosis (Fig. 4.1C).  The best studied example occurs 
in 64N polyploid megakaryocytes (Ravid et al., 2002), which are responsible for producing 
the anucleated platelets (or thrombocytes) that mediate blood-clotting (Ebbe, 1976).  
Endomitosis is distinguished by the presence of early mitotic markers such as phospho-
histone H3 (pH3), which marks condensed chromosomes (Hendzel et al., 1997).  
Endomitotic megakaryocytes reach metaphase or anaphase A, but never fully separate sister 
chromatids or undergo cytokinesis, resulting in globulated polyploid nuclei (Nagata et al., 
1997; Vitrat et al., 1998).  Endocycling cells, in contrast, do not display features of mitosis 
such as nuclear envelope breakdown, chromosome condensation, or pH3 staining.  Thus, 
evolution has resulted in multiple mechanisms for achieving endopolyploidy.  In the 
following sections we describe some of the biological functions of endopolyploidy. 
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Endoreplication is crucial for early development 
The evasion of controls that maintain diploidy may seem like a dangerous escapade 
for endoreplicating cells by opening up possibilities to upset genome integrity.  However, 
endoreplication is an essential part of normal development.  Many organisms employ 
endoreplication as part of terminal differentiation to provide nutrients and proteins needed to 
support the developing egg or embryo.  Some of the best studied examples include plant 
endosperm, Drosophila follicle and nurse cells, and rodent trophoblasts. The logical 
implication is that increasing DNA content by endoreplication is needed to sustain the mass 
production of proteins and high metabolic activity necessary for embryogenesis.  Disrupting 
endoreplication in these cells often leads to embryonic lethality. 
          Developing plant seeds depend on endosperm tissue as an energy store before 
becoming self-sufficient through photosynthesis and root formation (Fig. 4.2A).  Endosperm 
differentiation occurs soon after fertilization and is associated with a switch from a mitotic 
cell cycle to an endocycle. This initiation of endocycles correlates with an increase in 
endosperm mass and rapid synthesis of starch (Schweizer et al., 1995), suggesting that by 
increasing the number of individual loci, endoreplication is able to assist in maximizing 
mRNA and protein synthesis. The importance of endoreplication in seed development is 
evident after exposure to environmental stress, such as high temperature or water deficit. In 
these resource-limited settings, the endosperm remains primarily mitotic, and reduction in the 
magnitude of endoreplication leads to a smaller endosperm, unfit to support the embryo 
(Engelen-Eigles et al., 2001).  Another important polyploid cell type in early plant 
development is called the suspensor cell (Fig. 4.2A).   
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Figure 4.2: Examples of Endocycling Tissues.  A) A schematic and image of section of a plant embryo. The 
seed coat (a) covers the endosperm (b), which surrounds and provides nutrients for the growing cotyledons (c) 
and hypocotyl (d) of the embryo. Suspensor cells (e) arise from asymmetric division of the fertilized egg and 
connect the embryo to the endosperm and are thought to be crucial in nutrient transfer. B) Drosophila ovaries 
consist of 12-15 ovarioles (one is shown) containing a series of developing egg chambers. The germarium (far 
left) houses germ-line and somatic stem cells that differentiate into nurse cells and oocyte, and follicle cells 
respectively. Follicle cells switch to endocycles mid-oogenesis in response to Notch signaling, which down 
regulates stimulators of mitosis like stringcdc25 and activates inhibitors of mitosis like APCfzr/cdh1.  C) Rodent 
trophoblast giant cells are highly polyploid and facilitate implantation by contributing to invasion of placental 
tissue into the uterine wall.  D)The plant hypocotyl undergoes endocycles to rapidly grow above the ground. 
Once the young plant reaches the sun, hypocotyl endoreplication stops. 
After fertilization, a plant zygote undergoes asymmetric division to give rise to the 
embryo and suspensor cell (Gilbert, 2000). Suspensor cells employ endocycles to become 
polyploid, and provide nutrients to the embryo by bridging to the endosperm.  Although a 
direct effect of suspensor endoreplication on embryogenesis is unknown, cultured scarlet 
beans with suspensor cells were twice as likely to survive as embryos without suspensor cells 
(Yeung and Meinke, 1993). 
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In Drosophila melanogaster females, endoreplication is essential for the production 
of eggs.  The highly polyploid, germline-derived nurse cells form an interconnected cyst that 
shares cytoplasm with the oocyte, and support oogenesis by synthesizing and transferring 
proteins and mRNA to the growing oocyte (Fig. 4.2B). This maternal supply of gene 
products is essential to direct the early stages of embryogenesis, which occur in the absence 
of zygotic transcription (Bastock and St Johnston, 2008).  Somatic follicle cells are also 
polyploid and envelop the developing oocyte to enable vitellogenesis and egg shell 
formation.  Reduction of endoreplication in nurse and follicle cells causes sterility, 
supporting the idea that the endocycle plays a crucial role in oogenesis and early 
development (Lilly and Spradling, 1996; Maines et al., 2004).  
Because viviparous gestations do not require the same level of self-sufficiency as that 
of seeds or insect eggs, there is no truly comparable mammalian tissue to that of endosperm 
or nurse and follicle cells.  In rodents there is a specialized zygotic cell type that adopts the 
endocycle to establish the interface between the embryo and the mother to support 
embryogenesis (Zybina and Zybina, 2005). Trophoblast Giant Cells (TGCs) facilitate uteral 
implantation of the fertilized egg and metastasis into maternal blood vessels to allow 
transport of nutrients, oxygen, and immunoglobins into the embryo (Cross, 2000, 2005; 
Cross et al., 2002). TGCs differentiate from trophoectoderm that surround the early 
blastocyst. Differentiation is associated with rapid endocycling resulting in up to a 1000C 
DNA content (Cross, 2000). TGC endoreplication is not used to directly provide gene 
products to the embryo, but increased gene expression through polyploidy may supply the 
energy necessary for aggressive invasion into the maternal tissue (Fig. 4.2C).  In addition, a 
significant reduction in the magnitude of endoreplication in TGCs causes embryonic lethality 
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(Garcia-Higuera et al., 2008; Geng et al., 2003; Parisi et al., 2003).  Restoration of 
endocycling in these cells is sufficient to rescue embryonic viability, indicating that the 
endocycle also plays a crucial role in early mammalian development.  
 
Endoreplication supports the function of differentiated cells 
There are many examples of cells adopting endoreplication as part of terminal 
differentiation to support a specialized function. From plants to mammals, endoreplication is 
used to facilitate growth and to provide key functions to the adult organism, from nutrient 
uptake to defense. Perturbing endoreplication in these cells often causes organ malfunction 
and pathogenesis. 
 
Endoreplication and growth:   
Organisms can grow either via an increase in cell number or an increase in cell size, 
or both. Since an increase in DNA content often correlates with increased cell size, 
endoreplication provides an efficient strategy for growth.  For instance, producing the 
necessary surface area of cell membrane needed for several generations of cell division has 
been proposed to be slower and require more energy than simply increasing the volume of a 
single cell (Kondorosi et al., 2000). Thus, in situations where energy sources are limiting or 
rapid growth is necessary, increasing cell volume without division may be more 
advantageous (Kondorosi et al., 2000). Endoreplication in plants most commonly occurs in 
tissues that develop mass quickly and have high metabolic activity (Inze and De Veylder, 
2006).  One example of this occurs during early growth prior to photosynthesis, when the 
young hypocotyl emerges from the soil (Fig. 4.2D). This rapid growth is accomplished 
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through endoreplication (Jakoby and Schnittger, 2004).  After emergence, this early 
developmentally controlled endoreplication subsequently becomes impacted by the 
environment, as endocycles are negatively regulated by sunlight (Gendreau et al., 1998).  
While different than the endopolyploidy we have been discussing, it is interesting to note that 
the acquisition of a fully polyploid genome during the process of inbreeding or evolutionary 
selection may provide some plants with the advantage of a larger size and greater green mass 
over their diploid, subspecies counterparts (Ayala et al., 2000). Full genome polyploidy is 
commonly observed in cultivated plants such as coffee, watermelon, maize, potatoes, and 
bananas, among others.  Finally, overall growth of C. elegans and Drosophila larvae is also 
mainly driven by endoreplication (Edgar and Orr-Weaver, 2001; Lozano et al., 2006).  
However, it is important to remember that endoreplication-associated growth is usually 
confined to specialized cell types that perform specific biological functions and is not a 
universal mechanism to control organism size. It has long been known that variations in 
mammalian body size are due to differences in cell number alone and not cell size. In fact, 
cells from mice and elephants have similar sizes (Wilson, 1925). 
The correlation between polyploidy and cell size raises the question of whether 
endoreplication per se triggers growth or whether growth promotes endoreplication. The 
answer is likely not a unidirectional cause and effect relationship, but rather a mutual 
feedback between growth and endoreplication:  organism growth can be mediated by, and 
depend upon, an increase in cell size through endoreplication, while conversely inhibition of 
growth leads to reduction in endoreplication.  Genetic perturbations in C. elegans that result 
in reduced body size are associated with reduced endoreplication of hypodermal cells 
(Flemming et al., 2000). Similarly, starvation in insects reduces endoreplication (Britton and 
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Edgar, 1998), and nutrient deprivation through inhibition of the insulin signaling pathway 
also blocks endoreplication (Britton et al., 2002). In addition, mutation of the Drosophila 
myc oncogene, which in flies acts to induce growth, causes a dramatic decrease in 
endoreplication in both somatic and germline cells of the ovary (Maines et al., 2004). Since 
Myc over-expression stimulates growth and could rescue the reduction in endoreplication 
imposed by inhibitors of insulin signaling, it was proposed that the endoreplication defect 
observed in Drosophila myc mutants is a secondary consequence of growth arrest (Pierce et 
al., 2004).  
Endoreplication and nutrient utilization:  
Endoreplication is employed extensively in tissues reserved for nutrient uptake and 
storage. Plant leaves and root hairs undergo endoreplication (Kondorosi et al., 2000), as do 
intestinal cells in Drosophila and C. elegans (Hedgecock and White, 1985; Smith and Orr-
Weaver, 1991). Endoreplication in leaves and root hairs may aid in maximizing surface area 
to absorb light and water. However, whether polyploidy resulting from endoreplication is 
necessary for efficient or effective nutrient uptake has not been specifically addressed.  
Polyploid cells themselves can be used as an energy source. During metamorphosis, a 
Drosophila pupae is completely isolated from an exogenous food supply, and the biomass 
accumulated in polyploid cells during larval feeding is recycled for the differentiation and 
morphogenesis of adult tissues. Similarly, polyploid plant fruit tissue is utilized as energy for 
early plant development.  
Endoreplication and functional tissue morphology:  
Endoreplication is also used by tissues that are needed to maintain organism 
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homeostasis. Trichomes are a specialized, branched cellular structures made by polyploid 
epidermal cells found on the aerial surface of many plant tissues (Fig. 4.1A).  Trichomes can 
form irritable spines that work to deter herbivorous animals, keep frost away from other 
epidermal cells, or reflect ultra violet radiation in exposed areas. They can also reduce the 
degree of evaporation by blocking the flow of air across the surface, or enhance the 
collection of rain and dew (Galbraith et al., 1991; Hulskamp et al., 1999).  Trichome 
structure is dependent on the degree of cellular polyploidy resulting from endoreplication.  
Mutation of the SIAMESE  gene converts the normally unicellular trichomes of Arabidopsis 
into multicellular trichomes with reduced ploidy that sometimes have aberrant morphology 
(Walker et al., 2000).  Thus, some tissues may grow via endoreplication because this avoids 
the cell shape changes associated with mitosis.  The most recognized application of trichome 
structures are cotton fibers derived from the epidermal layer of the seed coat. These single 
cells differentiate through multiple rounds of endoreplication to become elongated “hair-like” 
structures.  The extent and function of this elongation primarily depends on the plant’s 
environment. In addition, plant root hairs allow the plants to become firmly rooted to the 
ground and the lack of this structure leads to instability (Menand et al., 2007).  
Utilization of endoreplication for tissue regeneration after stress  
Endoreplication can be employed for growth and tissue regeneration during 
conditions that would otherwise prevent proliferation (Weigmann et al., 1997).  By bypassing 
the controls that maintain genomic stability through diploidy, certain tissues react to 
exogenous stress by utilizing endoreplication to grow and retain cell and organ function. 
There are clear examples of this in both plants and animals, indicating that a switch to 
endoreplication is a conserved method to maintain homeostasis despite dire conditions.  
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In Arabidopsis, there is a distinct correlation between response to environmental 
stresses and endocycle-dependent leaf area (Cookson et al., 2006).  By over-expressing or 
mutating the gene encoding E2fe/DEL1, an atypical E2F transcription factor that acts to 
repress the endocycle (Vlieghe et al., 2005), Cookson et al. (2006) asked if the extent of 
endoreplication affected the plant’s ability to respond to shade or water deficit stress.  An 
increase in the extent of endoreduplication reduced the negative impact of water deficit on 
final leaf size.  This suggests that adaptation via endopolyploidy can provide protection to 
stress and thus increase organism fitness, perhaps by maintaining tissues such as leaves that 
have a high photosynthetic capability.  However, not all conditions were improved by 
endoreplication.  The same study showed that increased endoreplication reduced the ability 
of leaves to achieve proper size in response to shade, likely because switching to an 
endocycle prevented the compensatory increase in cell number, and thus leaf expansion, via 
proliferation necessary to properly combat the reduced available light. Thus, depending on 
the signal and the situation, the most beneficial stress response can be achieved by 
endoreplication or cell proliferation. 
A dramatic example of protective endoreplication in response to stress has been 
observed in animal cells (Lazzerini Denchi et al., 2006).  In many tissues, telomere 
dysfunction (e.g. shortening or de-protecting) induces senescence or apoptosis (Hemann et 
al., 2001; Herbig et al., 2004).  In contrast, hepatocytes in the liver do not apoptose in 
response to compromised telomeres that trigger a DNA damage response (Lazzerini Denchi 
et al., 2006).  In addition, while loss of telomere integrity blocks hepatocyte cell division, 
these cells can nonetheless regenerate functional livers that were damaged by partial 
hepatecomy, and they did so via endoreplication. Thus, endoreplication can provide a means 
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to achieve necessary growth in response to exogenous stress in a situation where 
compromised genome integrity precludes cell proliferation.  Similar stress-induced switches 
to endoreplication have been observed in tumor tissues responding to genotoxic insults 
(Ivanov et al., 2003), in damaged cardiomyoctes (Anatskaya and Vinogradov, 2007; Meckert 
et al., 2005), and in aging mouse hepatocytes (Funk-Keenan et al., 2008).  Thus, it is 
interesting to speculate that stress-induced endoreplication is a general mechanism to achieve 
an increase in tissue mass and regain essential functions in response to compromised 
genomic integrity.   
Endoreplication as a default program upon mitotic catastrophe in both cancer and 
normal cells 
Endoreplication has been observed in cancer cells for many decades (Storchova and 
Pellman, 2004). Early studies were aimed at understanding the mechanisms by which cancer 
cells became polyploid.  Whether endoreplication is a causative agent in oncogenic 
transformation or progression is also not yet entirely clear.  One possibility is that 
polyploidization is a precursor to aneuploidy that may contribute to oncogenesis (Storchova 
and Pellman, 2004) (Fig. 3).  
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Figure 4.3: Common Uses of the Endocycle during Normal and Cancer Development 
Another possibility is that cancer cells use endoreplication as a means of survival 
during mitotic catastrophe or genotoxic stress.  For instance, some p53 mutant cancer cells 
undergo endoreplication rather than apoptosis upon treatment with anti-mitotic drugs such as 
colcemid and vinblastine [for review: (Erenpreisa et al., 2005a)].  This induces a form of 
endomitosis that appears for the most part to be a senescent situation.  However, at low 
frequency some of these polyploid cancer cells can actually revert back into mitotic cell 
cycles via a process of genome reduction called de-polyploidization (Erenpreisa et al., 2005a; 
Erenpreisa et al., 2005b; Prieur-Carrillo et al., 2003; Puig et al., 2008).  Human embryonic 
cells infected with SV-40 virus and subsequent inactivation of p53, and fibroblasts 
undergoing senescence, endoreplicate. These cells can also successfully de-polyploidize 
(Walen, 2002, 2007a, b). 
Survival from anti-mitotic drug treatment by endoreplication and subsequent de-
polyploidization suggests a mechanism for how cancer cells become insensitive to anti-
mitotic drugs. Could this also contribute to recurrence of more aggressive cancer? Not only 
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can endoreplication prolong the existence of cancer cells, it may also promote the selection 
of additional oncogenic mutations resulting from repeated rounds of replication in a cell that 
might have compromised the fidelity of DNA synthesis. Consequently, de-polyploidization 
and re-entering the mitotic cycle after endoreplication could result in daughter cells with 
different genotypes, some of which might be highly cancerous.  
What might be the mechanism of de-polyploidization, which seems so 
counterintuitive? While the mechanism is unknown, some features of genome structure and 
organization in cells that undergo induced endoreplication (e.g. with mitotic spindle poisons) 
are likely important. The genome is likely to be completely replicated during cancer cell 
endomitosis, and the nuclear packaging of the condensed, duplicated chromosomes may be 
advantageous in facilitating polyploid genomes to be separated during de-polyploidization 
(Erenpreisa et al., 2005a; Erenpreisa et al., 2005b).  Curiously, cancer cells that undergo de-
polyploidization activate meiosis specific genes (Erenpreisa et al., 2009; Ianzini et al., 2009), 
but how this might contribute to de-polyploidization or if the de-polyploidization process 
resembles in any way the reductional division of meiosis is not entirely clear (Erenpreisa et 
al., 2005a). 
Other polyploid genomes display characteristic variations in organization and 
structure that likely preclude a return to mitotic proliferation.  For example, unlike cancer cell 
endomitosis, the endocycles that generate polyploid cells during Drosophila development 
under-replicate the pericentric heterochromatin and thus do not duplicate the entire genome 
each endocycle S phase (Lilly and Duronio, 2005).  In addition, some cells organize their 
polyploid genome by aligning the multiple copies of sister chromatids along their lengths, 
leading to giant polytene chromosomes that contain a distinct banding pattern (Dej and 
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Spradling, 1999).  This is perhaps most famous in the Drosophila salivary gland, but 
polytene chromosomes are also observed in plant ovules, leaves, roots and some tissues of 
the pollen sacs (Kondorosi and Kondorosi, 2004). The functional significance for why a 
polyploid genome becomes polytene is not well understood.  Nevertheless, polyteney 
coupled with incomplete replication of the whole genome, particularly centromeres, 
represents a terminally differentiated state that is not conducive to de-polyploidization and a 
return to proliferative cycles.   
Certain non-cancerous cells can also be induced to undergo endoreplication upon 
mitotic stress, in contrast to most cells that arrest from mitotic checkpoints and/or undergo 
apoptosis.  For over 70 years, plant biologists have used colchicine to induce polyploidy 
(Eigsti, 1938).  Likewise, nocodazole treatment of keratinocytes also results in 
endoreplication (Gandarillas et al., 2000).  Mammalian cells deficient of Fbw7, which 
encodes a component of a Cullin-RING E3 ubiquitin ligase (Koepp et al., 2001; Strohmaier 
et al., 2001), were shown to induce endoreplication upon exposure to spindle toxins (Finkin 
et al., 2008).  It will be interesting to determine whether the resumption of proliferation via 
de-polyploidization in cells that undergo endomitosis-like endoreplication is utilized during 
normal development or part of normal tissue homeostasis. Intriguingly, de-polyploidization 
has been recently noted in hepatocytes (Duncan et al., 2009).   
TRANSITION INTO ENDOREPLICATION 
Given that endoreplication is a crucial component of development and disease, an 
understanding of the molecular controls that govern the switch from mitotic cycles to 
 108 
endoreplication is important.  In the following sections, we will examine some of the best 
characterized examples of the developmental signals controlling the onset of endoreplication. 
Endocycles induced by Notch signaling 
During development, endocycling cells originate from proliferating diploid cells, 
which undergo conversion of the cell cycle as part of their program of differentiation.  
Studies of follicle cells in the Drosophila ovary have provided the most detailed paradigm for 
the developmental signals that regulate this type of cell cycle transition.  Follicle cells are 
derived from somatic stem cells and proliferate to give rise to ~650 diploid cells 
encapsulating the germ line cells (i.e. nurse cells and oocyte) (Bastock and St Johnston, 
2008). The mitosis to endocycle transition occurs midway through oogenesis and marks the 
beginning of terminal differentiation of follicle cells. Subsequently, follicle cell 
endoreplication drives the production of proteins and mRNAs that support vitellogenesis and 
formation of the egg shell, or chorion. 
Studies in the last decade have indicated that Notch signaling is a key regulator of the 
follicle cell mitotic to endocycle transition. Notch is a transmembrane receptor that binds 
Delta or Serrate (Jagged in vertebrates) ligands, activating cleavage of Notch’s intracellular 
domain which enters the nucleus to regulate transcription of Notch-responsive genes [For 
reviews: (Gordon et al., 2008; Poellinger and Lendahl, 2008; Talora et al., 2008)]. Notch 
mutant follicle cells do not switch to endocycles and continue to mitotically divide and 
express undifferentiated markers (Deng et al., 2001; Lopez-Schier and St Johnston, 2001).  
Conversely, ectopic expression of Delta leads to precocious initiation of follicle cell 
endocycles (Jordan et al., 2006). Hedgehog (Hh) signaling antagonizes Notch by promoting 
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the proliferation of follicle cells, and mutations in patched, a negative regulator of Hh 
signaling, leads to mitotic cycles at stages when endocycling normally occurs (Zhang and 
Kalderon, 2000). 
 
Figure 4.4: Regulation of the endocycle.  A complex array of controls ensures once and only once replication 
during endocycle progression.  The key players are shown when they are active (green, solid lines) or inactive 
(red, dashed lines) in either the G or S phase of the endocycle.  Control of CycE/Cdk2 activity forms the core of 
endocycle regulation.  CycE and CycE/Cdk2 activity are low during G phase when APC/Cfzr/cdh1 represses 
accumulation of Geminin, thereby allowing pre-RC formation.  E2F1 stimulation of CycE transcription 
contributes to activation of CycE/Cdk2 and the initiation of DNA replication, which triggers E2F1 destruction.  
CycE/Cdk2 directly represses pre-RC formation and inactivates APC/Cfzr/cdh1, which allows Geminin 
accumulation that also inhibits pre-RC formation. 
Recent studies have shed much light onto the mechanisms by which Notch signaling 
promotes the transition into endocycles (Fig. 4.4). In general, Notch promotes changes in 
gene expression resulting in the down-regulation of mitotic functions and the up-regulation 
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activities needed for endoreplication.  Notch signaling is known to modulate three important 
genes in this process:  It induces expression of fizzy-related (fzr/Cdh1), an activator of the 
Anaphase Promoting Complex/Cyclosome (APC/C) that triggers ubiquitin-mediated 
destruction of mitotic cyclins (Morgan, 2007), and it represses expression of the S-phase 
CDK-inhibitor dacapo (dapp27) and stringcdc25, a phosphatase that activates Cyclin/Cdk1 
complexes needed for mitosis (Deng et al., 2001; Schaeffer et al., 2004; Shcherbata et al., 
2004).  These Notch-induced changes in gene expression are necessary.  For instance, 
mutations affecting fzr/Cdh1 result in uncharacteristically small follicle cell nuclei due to a 
failure to switch into endocycles (Schaeffer et al., 2004).  Likewise, mutation of Shaggy 
(sgg), the Drosophila GSK3 kinase, prevents Notch intracellular domain cleavage and a 
failure to both down regulate stringcdc25 and express endocycling follicle cell markers (Jordan 
et al., 2006). 
Several transcription factors respond to Notch signaling to control the mitotic to 
endocycle transition in follicle cells.  Notch activates a transcription factor called Hindsight 
that mediates the down regulation of the Hh pathway as well as the down regulation of the 
homeodomain protein Cut, which is a repressor of fzr/Cdh1 expression (Sun and Deng, 2005, 
2007). Notch-mediated Hindsight expression is also crucial for down-regulating stringcdc25, 
which when mutated causes precocious activation of endocycles (Sun and Deng, 2005). 
Similarly, the absence of the zinc-finger transcription factor tramtrack (ttk), a downstream 
target of Notch signaling, resulted in misregulation of stringcdc25, dacapo, and fzr/Cdh1 
causing a failure to transition into endocycles (Jordan et al., 2006).  Thus, Notch signaling 
facilitates the mitotic to endocycle switch by regulating transcription factors that mediate the 
repression of genes needed for mitosis (e.g. stringcdc25) and the activation of genes that 
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stimulate destruction of mitotic regulators (e.g. fzr/Cdh1).  Whether the fzr/Cdh1, dacapo or 
stringcdc25 genes are direct targets of these transcription factors is not known. 
Interestingly, modulation of Notch signaling has also been implicated in the 
termination of follicle cell endocycles. In later stages of Drosophila oogenesis, follicle cells 
terminate endoreplication and undergo another transition in which genes needed for chorion 
formation become specifically amplified via re-initiation of origins of replication (Calvi and 
Spradling, 1999; Tower, 2004).  Such gene amplification on top of endocycle-mediated 
polyploidization is needed to generate the gene copy number to support sufficient 
biosynthesis of proteins needed for eggshell production. Down-regulation of Notch signaling 
plays a crucial role in conjunction with ecdysone hormone signaling to promote the switch 
from endocycles to gene amplification (Sun et al., 2008). 
Notch signaling may contribute to the transition from mitotic to endocycles in 
mammals as well. More than a decade ago, tissue specific Notch signaling factors were 
identified in trophoblast giant cells and were proposed to down-regulate the Mash-2 
transcription factor, a step that is necessary for giant cell differentiation (Nakayama et al., 
1997). Targeted deletion in mice of the F-box protein, Fbw7, results in elevated levels of 
Notch signaling and an increased number of trophoblast giant cells undergoing 
endoreplication (Tetzlaff et al., 2004). In addition, a requirement for Notch in megakaryocyte 
differentiation was recently described (Mercher et al., 2008).  
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Hormone-induced endoreplication in plants and animals 
Notch signaling is not conserved in plants, and as plants possess some of the best 
characterized examples of developmentally regulated endoreplication, there is still much to 
learn about the signals that regulate the onset and the degree of endoreplication.  Studies in 
plants as well as megakaryocytes in mammals suggest that hormone-induced pathways are 
also crucial for the transition to endoreplication.  
Plants: Many genes that affect endoreplication in plant development have been 
identified through mutational studies (Inze and De Veylder, 2006; Sugimoto-Shirasu and 
Roberts, 2003). Interestingly, it appears that there are tissue-specific pathways that are 
responsible for endoreplication. The phytohormone gibberellin (GA) acts antagonistically to 
salicylic acid to initiate endocycles in trichomes and the hypocotyl (Collett et al., 2000; 
Joubes and Chevalier, 2000). GA signals are mediated through GIS transcription factors and 
zinc-finger protein 8 to upregulate the expression of GL1, a potent transcriptional activator of 
endocycles (Gendreau et al., 1999). Mutations in the GA pathway exhibit defects in 
endoreplication, leading to smaller or less branched trichome structures and hypocotyl 
elongation (Gendreau et al., 1998; Gendreau et al., 1999). Spy is a negative regulator of GA 
and its mutation causes over-endoreplication phenotypes similar to wildtype plants treated 
with high concentration of GA (Swain et al., 2002). In the roots, ethylene and auxin promote 
root hair formation and elongation. Thus, phytohormones are thought to mediate the fate 
determination of endocycling cells, as well as the magnitude of endoreplication. However, 
whether these signals actually initiate the transition into endocycles is not yet clear. It has 
been suggested that specific combinations of phytohormones, nutrient, and light trigger 
endoreplication(Kondorosi et al., 2000). 
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Megakaryocytes:  Abnormal megakaryocyte function resulting in changes to the 
normal number of platelets is directly attributable to hematopoietic pathologies (Nurden, 
2005). Megakaryocyte ploidy is sometimes affected in patients with thrombocytopenia (low 
platelet counts) and thrombocytosis (high platelet counts), suggesting that endomitosis is 
important for efficient platelet formation (Pang et al., 2005; Tomer et al., 1989). However, 
the detailed mechanisms by which megakaryocyte ploidy is regulated are still not well 
understood.  
Thrombopoietin (TPO) is a cytokine that stimulates differentiation of megakaryocyte 
progenitor cells by binding its receptor, c-Mpl (Kaushansky, 2005, 2008). Injection of 
recombinant c-Mpl into normal mice increased platelet counts and megakaryopoiesis 
(Kaushansky et al., 1994).  Recombinant TPO has been shown to induce megakaryocyte 
maturation and polyploidization in vitro (Kaushansky, 1995). In addition, c-mpl or tpo 
mutations in mice or human patients exhibit reduced polyploidy of megakaryocytes and 
severe thrombocytopenia (Alexander et al., 1996; Gurney et al., 1994; Ihara et al., 1999; 
Murone et al., 1998; Solar et al., 1998).  
TPO mediates proliferative signals largely through JAK/STAT pathways (Drachman 
et al., 1999), while endomitosis signals seem to be mediated by ERK1/2 (Rojnuckarin et al., 
1999). Megakaryocytes from mice expressing a truncated version of c-mpl did not efficiently 
activate ERK, leading to reduced endomitosis after TPO induction (Luoh et al., 2000).  
Although the mechanisms by which these signals are transduced are not well understood, 
evidence suggests that TPO-induced endomitosis also relies on similar downstream factors as 
Notch-induced endocycles.  Differentiating megakaryocytes were shown to maintain high 
levels of the S-phase promoting G1 cyclin, CycE, and ectopic expression of CycE could 
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induce promegakaryocytes into endomitosis (Garcia and Cales, 1996; Garcia et al., 2000). 
Studies of different megakaryoblastic cell lines suggest that endomitosis is promoted by the 
down-regulation of cyclin B/cdk1 mitotic kinase activity, similar to what occurs in 
Drosophila endocycles (Datta et al., 1996; Kikuchi et al., 1997; Matsumura et al., 2000; 
Zhang et al., 1996).  
 
THE REGULATION OF THE ENDOCYCLE 
After the mitotic to endocycle transition, progression through the endocycle is 
coordinated by a subset of the same factors that control progression through mitotic cell 
cycles. These factors form a complex regulatory network that produce oscillations in the 
activity of cyclin dependent kinases that control DNA synthesis, resulting in alternating S 
and G phases leading to polyploidy.  
Replication origin control via oscillations of Cyclin E/CDK2 drive the endocycle 
To maintain genomic integrity, proliferating diploid cells must duplicate the entire 
genome once, and only once, per cell division cycle. This task is complicated by the fact that 
during S phase eukaryotic cells initiate DNA replication at many distinct sites in the genome 
(i.e. origins of replication).  Highly conserved mechanisms exist to control origin initiation 
during S phase, and to prevent origin re-initiation, and thus inappropriate re-replication of 
portions of the genome, within a given S phase and the subsequent G2.  This occurs through 
the regulated assembly of pre-replicative complexes (pre-RCs) at each origin during G1 
phase. The pre-RC is a multiprotein complex consisting of the hexameric Origin Recognition 
Complex (ORC), Cdc6, and Cdc10 dependent transcript1 (Cdt1).  These proteins recruit the 
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replicative DNA helicase, which is composed of the MCM2-7 complex (MCM=mini-
chromosome maintenance) and the GINS complex (Labib and Gambus, 2007). Once DNA 
synthesis is initiated at an origin, a variety of mechanisms that act on individual pre-RC 
proteins, including nuclear export, inactivating modification (e.g. phosphorylation), and 
ubiquitin-mediated degradation, prevent pre-RCs from reassembling until the next G1 [For 
review: (Arias and Walter, 2007)].  Importantly, the current data suggest that, as with diploid 
cells, these same origin controls are operative during endocycles (Edgar and Orr-Weaver, 
2001).  
Progression through both cell division cycles and endocycles is directed by periodic 
activation and inactivation of cyclin-dependent kinases (CDKs).  The last 20 years of cell 
cycle research has revealed an elegant molecular paradigm for S phase control in which a 
period of low CDK activity (e.g. during G1) is permissive for pre-RC assembly, while a 
period of high CDK activity (e.g. during S) both triggers the initiation of DNA synthesis and 
blocks the re-assembly of pre-RCs.  As a result, after the completion of S phase cells must 
sufficiently reduce CDK activity to become competent for another round of DNA replication.  
In cell division cycles this happens during mitosis, when several mechanisms (e.g. cyclin 
destruction) lead to a period of low CDK activity during G1.  In endocycles, CDK activity 
oscillates between high (S phase) and low (G phase) to achieve the repeated rounds of DNA 
replication resulting in polyploidy. 
In metazoan cell division cycles, activation of Cdk2 by S phase cyclins drives entry 
into S phase, while activation of Cdk1 by M phase cyclins promotes entry into and 
progression through mitosis (Morgan, 2007).  Mitotic Cdks are expressed at very low levels 
in endocycles (Narbonne-Reveau et al., 2008; Zielke et al., 2008), and endoreplication is 
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driven by periodic activation/deactivation of S phase Cdks.  In mammals the Cdk 
requirement for S phase, including endo S phase, is provided redundantly between Cdk1 and 
Cdk2 (Aleem and Kaldis, 2006; Aleem et al., 2005; Santamaria et al., 2007; Ullah et al., 
2008), whereas in Drosophila Cdk2 is essential (Lane et al., 2000).  CycE function is 
required for endoreplication in rodent trophoblasts and megakaryocytes (Geng et al., 2003; 
Parisi et al., 2003), and mutation of the single Drosophila CycE gene blocks DNA synthesis 
in both proliferating and endocycling cells (Knoblich et al., 1994).  Thus, CycE/Cdk2 
appears to be a major Cdk regulator of the endocycle in both insects and mammals (Fig. 4).   
CycE/Cdk2 promotes DNA replication in several ways (Sclafani and Holzen, 2007).  
For example, CycE expression can drive the chromatin loading of MCM proteins in 
Drosophila endocycling cells (Su and O'Farrell, 1998), as it does in mitotic mammalian cells 
that are stimulated to leave quiescence by serum addition (Coverley et al., 2002; Geng et al., 
2003).  Importantly, CycE/Cdk2 can also direct dissociation of pre-replication members from 
origins to inhibit re-loading of the MCM helicase (Arias and Walter, 2007).  Thus, 
CycE/Cdk2 both triggers S phase and subsequently inhibits re-replication within S phase. 
Consequently, a prevailing model of endocycle regulation is that periodic activation, or 
oscillation, of CDK2 activity both promotes endocycle progression and ensures once and 
only once replication during each endocycle S phase.  In support of this model, constitutive 
expression of CycE stalls endocycles in Drosophila salivary glands (Follette et al., 1998; 
Weiss et al., 1998).  Interestingly, continuous CycE expression is permissive for mitotic 
cycles, as occurs naturally in early embryogenesis (Jackson et al., 1995; Sauer et al., 1995), 
and during gene amplification in Drosophila ovarian follicle cells (Calvi et al., 1998).  These 
observations suggest that endocycle regulation is particularly dependent upon oscillation in 
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CycE/Cdk2 activity.   
How is the oscillation of CycE/Cdk2 activity during an endocycle achieved? There 
are both transcriptional and post-transcriptional inputs.  In Drosophila endocycles, CycE 
mRNA abundance oscillates during endocycles, with peak levels in late G and S phase.  
CycE expression in endocycling cells requires the E2F1 transcription factor (Duronio et al., 
1998; Duronio and O'Farrell, 1995; Royzman et al., 1997).  We will elaborate on this aspect 
of CycE regulation in a following section.  Studies in mammals and Drosophila revealed that 
a Cullin-RING E3 ubiquitin ligase (CRL) of the SCF type is responsible for regulated CycE 
protein destruction (Koepp et al., 2001; Moberg et al., 2001; Strohmaier et al., 2001). 
Drosophila Archipelago (Ago; Fbw7 in mammals) is an F-box protein that acts as a substrate 
receptor for the SCF ubiquitin ligase by directly binding to CycE (Moberg et al., 2001). ago 
mutants fail to undergo endocycles in ovarian follicle cells, leading to small nuclei 
(Shcherbata et al., 2004). Thus, when CycE transcription is terminated in late endo S phase, 
CycE protein destruction likely contributes to a decline in CycE/Cdk2 activity necessary for 
the period of low CDK activity that is permissive for pre-RC assembly.  CycE protein 
destruction may also contribute to mammalian endocycles.  Fbw7 null mutant mice display 
elevated levels of CycE in trophoblasts, which display defects in endoreplication (Tetzlaff et 
al., 2004). Similarly, mice that lack Cullin1 activity exhibit elevated levels of CycE in 
trophoblasts, which fail to undergo endoreplication (Tateishi et al., 2001).  However, these 
observations may be a result of CycE over-expression rather than changes in oscillations of 
CycE expression, since fluctuations of neither CycE protein nor mRNA were detected in 
trophoblasts (Geng et al., 2003).  
This last observation suggests that additional regulators contribute to oscillations in 
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CycE/Cdk2 activity during endocycles.  Likely candidates include CDK inhibitors, or CKIs, 
which bind to and inhibit CDK kinase activity (Morgan, 2007). The level of the p57 CKI 
oscillates during rodent trophoblast giant cell endocycles (Hattori et al., 2000), with the 
greatest amount during G phase (Ullah et al., 2008).  p57 activity was recently shown to 
promote endoreplication through down-regulating CDK1 (Ullah et al., 2008).  Similarly, 
expression of the Drosophila CKI Dacapo, which inhibits CycE/Cdk2, oscillates in ovarian 
nurse cells (de Nooij et al., 2000) and follicle cells (Hong et al., 2007).  Furthermore, Dacapo 
expression in nurse cells is stimulated by CycE, suggesting negative feedback regulation that 
may be important for endocycle progression (de Nooij et al., 2000).  Mutation of dap disrupts 
nurse cell endoreplication, suggesting that Dap functions to enforce the period of low 
CycE/Cdk2 activity needed for pre-RC assembly (Hong et al., 2007).     
The existence of multiple mechanisms that each contribute to oscillations in 
CycE/Cdk2 activity creates the potential for variations in endocycle regulation in different 
cell types.  Some evidence from Drosophila supports this idea.  For example, ovarian nurse 
cell endocycles are disrupted in dap mutants (Hong et al., 2007), but both endocycling 
ovarian follicle cells and endocycling socket and shaft cells of mechanosensory bristles do 
not express dap, and thus likely do not require Dap function (Audibert et al., 2005; 
Shcherbata et al., 2004).  In the salivary gland, transcriptional control of CycE expression 
appears to be more important than in nurse cells, where CycE protein levels oscillate (Lilly 
and Spradling, 1996), but CycE mRNA levels do not (Royzman et al., 2002).  Multiple 
mechanisms of CycE/Cdk2 control lead to increased robustness of endocycle progression and 
provide an opportunity for multiple regulatory inputs that may differentially utilized in 
different cell types. 
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Ubiquitin-mediated proteolysis promotes endocycle progression 
Ubiquitin-mediated proteolysis plays an important role in both endocycle initiation 
and progression (Ullah et al., 2009).  The key regulator is the Anaphase Promoting 
Complex/Cyclosome (APC/C), an E3 ubiquitin ligase best known for its role in targeting 
proteins (e.g. cyclins)  for destruction during mitosis (Morgan, 2007).  To target specific 
proteins for ubiquitination and destruction, the APC/C interacts with two activator proteins, 
fzy/Cdc20 and fzr/Cdh1, which effectively function as substrate receptors for the APC at 
different points in the cell cycle.  APC/Cfzy/Cdc20 is active only during mitosis and triggers the 
metaphase to anaphase transition, while APC/Cfzr/Cdh1 is active from the metaphase/anaphase 
transition through the subsequent G1.  One of the jobs of APC/Cfzr/Cdh1 is to prevent mitotic 
cyclin accumulation during G1.  This helps maintain a period of low CDK activity necessary 
for pre-RC formation.  It is this job that is important for the mitotic to endocycle transition, 
as first shown in Drosophila fzr/Cdh1 mutant embryos, which inappropriately accumulate 
mitotic cyclins and fail to enter endocycles (Sigrist and Lehner, 1997).  As discussed above, 
Notch signaling induces fzr/Cdh1 expression during the mitotic to endocycle transition in 
Drosophila follicle cells.  Similarly, genetic inhibition of a plant ortholog of fzr/cdh1, ccs52, 
results in inhibition of endocycles (Cebolla et al., 1999) and mutation of mutation of mouse 
fzr blocks trophoblast giant cell endoreplication (Garcia-Higuera et al., 2008), suggesting that 
APC/Cfzr/Cdh1 involvement in the mitotic to endocycle transition is an evolutionarily ancient 
mechanism.  However, from these data it was unclear whether APC/C activity is needed 
during endocycle progression.  
Recent reports from two groups revealed APC/C activity is necessary to sustain 
endocycle progression in Drosophila, in part by targeting the Geminin protein for destruction 
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(Narbonne-Reveau et al., 2008; Zielke et al., 2008).  Geminin is an inhibitor of DNA 
replication, and acts by binding directly to Cdt1 and preventing Cdt1 from recruiting the 
MCM2-7 helicase to pre-RCs (Wohlschlegel et al., 2000).  In mitotic cycles, Geminin is 
targeted for destruction by APC/C at the metaphase-anaphase transition, and does not re-
accumulate until late G1 when APC/C is inactivated by G1 Cyclin/Cdk-mediated 
phosphorylation of Cdh1 (McGarry and Kirschner, 1998; Zachariae et al., 1998).  Genetic 
depletion of APC/C components in Drosophila follicle cells and salivary glands results in 
Geminin hyper-accumulation and disrupts endocycle progression, likely because pre-RC 
formation is inhibited (Narbonne-Reveau et al., 2008; Zielke et al., 2008).  Conversely, 
mutation of Geminin causes premature endoreplication during early mouse embryogenesis 
(Gonzalez et al., 2006). 
Geminin protein accumulation oscillates in unperturbed Drosophila endocycles, with 
high levels occurring during S phase and low levels during G phase (Zielke et al., 2008).  
This cyclic expression likely helps constrain Cdt1 activity to G phase when pre-RCs are 
formed, and helps prevent re-replication during endo S phase.  How is cyclic Geminin 
accumulation achieved? Narbonne-Reveau et al. (2008) show that APC/C activity also 
oscillates in endocycles.  They suggest that CycE/Cdk2 promotes the phosphorylation and 
inhibition of fzr/Cdh1, which prevents the APC/C from acting on its targets resulting in 
accumulation of Geminin during S phase.  The model which emerges is that APC/Cfzr/Cdh1 
plays a critical role in the G phase of an endocycle by stimulating pre-RC assembly in two 
ways: 1) targeting the Cdt1 inhibitor Geminin for destruction and 2) maintaining low levels 
of mitotic CDK activity.  In this way APC/Cfzr/Cdh1 acts much like it does during G1 phase of 
a mitotic cycle, suggesting that endocycles are essentially G1-
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APC/Cfzr/Cdh1 activity are directly, and inversely, tied to cycles of CycE/Cdk2 activity, thus 
forming a key component of the endocycle regulatory circuit (Fig. 4). 
While inappropriate Geminin hyper-accumulation may be sufficient to block 
endocycles, there are likely other targets of the APC/Cfzr/Cdh1 that must be kept low for 
normal endocycle progression to occur.  For instance, in Drosophila salivary glands, 
preventing Geminin accumulation does not relieve the block to endoreplication in conditions 
where APC/Cfzr/Cdh1 is held inactive by over-expression of CycE (Narbonne-Reveau et al., 
2008).  Mitotic cyclins are targets of APC/Cfzr/Cdh1, and Cyclin A activity can suppress 
endocycles in both flies and plants (Hayashi, 1996; Imai et al., 2006; Sauer et al., 1995).  
Thus, in the absence of APC/Cfzr/Cdh1 activity the inappropriate accumulation of Cyclin A 
could also contribute to endocycle arrest by ectopically activating CycA/Cdk1 and inhibiting 
pre-RC assembly. 
Transcriptional control of the endocycle   
As noted above, transcriptional controls via a variety of factors play an important role 
in endoreplication.  Some of these factors affect the activity of CycE/Cdk2, and thus 
contribute to the core endocycle mechanism, while others regulate the transition into 
endocycles and/or contribute to the differentiated state that is permissive for endoreplication. 
Modulation of endocycle progression by E2F 
The E2F family of transcription factors regulates the G1-S transition in both mitotic 
and endocycling cells by controlling genes encoding factors necessary for DNA synthesis 
and S phase progression (DeGregori and Johnson, 2006; Dimova and Dyson, 2005; van den 
 122 
Heuvel and Dyson, 2008).  The E2F family is composed of positive and negative regulators 
of transcription, and both types play a role in endocycle progression in animals and plants 
(Boudolf et al., 2004; Duronio et al., 1998).  In Drosophila E2f1 mutants, DNA synthesis and 
endocycle progression is drastically attenuated (Duronio et al., 1998; Duronio et al., 1995; 
Royzman et al., 1997), similar to observations made in trophoblast giant cells in a mouse 
mutant of DP1, the obligate binding partner of E2F (Kohn et al., 2003).  Therefore, at least 
some E2F transcriptional targets must be important for endocycle progression, even though 
recent reports indicate that in Drosophila these targets are expressed at lower levels than in 
mitotic cells (B. Calvi, pers. comm.; (Zielke et al., 2008)).  Drosophila E2f1/Dp is required 
for the expression of a host of replication factors during endoreplication.  However, the key 
E2F target is the CycE gene, whose expression both oscillates and requires E2f1 and Dp 
during Drosophila endocycle progression (Duronio et al., 1998; Duronio and O'Farrell, 1995; 
Duronio et al., 1995; Royzman et al., 1997).  Interestingly, Drosophila CycE also negatively 
regulates its own expression by down-regulating E2f1 activity (Duronio et al., 1995; Sauer et 
al., 1995).  These data suggest a model whereby E2F-directed transcriptional regulation of 
CycE contributes to the oscillations of CycE/Cdk2 activity that are critical for endocycle 
progression (Fig. 4.4). 
How might cycles of E2f1 activation and inhibition occur?  Very recent work has 
provided new insight into the mechanism.  The most well studied mode of E2F regulation is 
via E2F interaction with the retinoblastoma family of tumor suppressor proteins, which are 
conserved in both insects and plants (Inze and De Veylder, 2006; van den Heuvel and Dyson, 
2008).  pRb family proteins bind and inhibit E2F during periods of low CDK activity (i.e. 
G1).  However, mutations in Drosophila Rbf1, which binds and inhibits E2f1, do not affect 
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endocycle progression (Du, 2000; Du and Dyson, 1999; Du et al., 1996), suggesting the 
possibility for a pRb-independent mode of regulation.  Like its transcriptional targets and 
other regulators that we have discussed, E2f1 protein accumulation oscillates during 
endocycles, with high levels during G phase and low levels during S phase (Zielke et al., 
2008).  We recently demonstrated that E2f1 is targeted for destruction in replicating cells by 
a mechanism requiring a motif in the E2f1 protein called a PIP box (Shibutani et al., 2008), 
which interacts with PCNA bound to chromatin at replication forks (Arias and Walter, 2006; 
Havens and Walter, 2009; Higa et al., 2006; Hu and Xiong, 2006; Senga et al., 2006).  This 
interaction recruits a Cul4Cdt2 E3 ubiquitin ligase that targets E2f1 for destruction (Shibutani 
et al., 2008).  This suggests a model in which accumulation of E2f1 during G phase drives 
CycE transcription, which activates Cdk2 and triggers entry into S phase and the subsequent 
destruction and inactivation of E2f1.  The resulting down regulation of CycE transcription 
and destruction of CycE protein (described above) create the period of low CDK activity in 
the following G phase where origins are assembled in preparation for the next cycle.  A 
predication of this model is that blocking S phase-coupled E2f1 destruction will attenuate 
endocycle progression.  Indeed, expressing a mutant version of E2f1 lacking a functional PIP 
box results in continuous CycE expression and blocks the endocycle in larval salivary glands 
(B.A. Edgar, pers. comm.).  Interestingly, the same E2f1 mutant does not block cell 
proliferation, even though E2f1 protein is destroyed during S phase in cell division cycles 
(Shibutani et al., 2008).  This again illustrates that endocycles and cell division cycles 
contain common modes of regulation, but depend differently on these forms of regulation for 
cell cycle progression.  In addition, because robust oscillations of CycE transcription are not 
observed in ovarian nurse cells (Royzman et al., 2002), it will be interesting and important to 
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determine if S phase-coupled E2f1 destruction is important in all endocycles. 
Modulation of endocycle progression by repressor E2Fs.   
Plants also contain pRb and both repressor and activator E2Fs.  Tobacco pRb function 
modulates the extent of endoreplication, as disruption of pRb resulted in increased 
endoreplication (Park et al., 2005).   Similarly, functional reduction of the Arabidopsis 
E2fc/DPB repressor results in higher proliferation activity, yet a severe reduction in organ 
size because cells are unable to switch to endoreplication-mediated growth (del Pozo et al., 
2006). Thus, pRb/E2F pathways regulate a balance between proliferation and 
endoreduplication during development that is a critical feature of plant growth and final 
organ size.  In Drosophila, the absence of the E2f1 activator results in the E2f2 repressor 
acting to inhibit proliferation, likely by repressing cell cycle targets of E2f1 (Frolov et al., 
2001; Rasheva et al., 2006).  In the absence of both E2f1 and E2f2, some endocycles are 
inhibited because of elevated, continuous expression of CycE  (Weng et al., 2003).  
A recently described family of atypical E2F repressors plays an important role in 
endocycle initiation in plants.  These E2F repressors are also found in animals, and contain 
two DNA binding domains, do not bind to DP, and lack an obvious pRb interaction domain 
(Lammens et al., 2009).   E2fe/DEL1 is an Arabidopsis atypical E2F expressed in mitotically 
active cells that controls the timing of endocycle onset by repressing the expression of a 
homolog of fzr/Cdh1 (called CCS52A2) (Lammens et al., 2008; Vlieghe et al., 2005).  As in 
Drosophila, Arabidopsis APC/CCdh1 triggers endocycle onset by triggering the destruction of 
mitotic cyclins and the consequent inhibition of mitotic CDK activity (Boudolf et al., 2009).  
Such regulation may be conserved in mammals, since human E2f7 associates with the 
 125 
promoter of the Cdh1 gene (Lammens et al., 2008).   
Other transcriptional inputs into endoreplication.  
Transcription factors other than E2F have been implicated in the initiation and 
maintenance of endocycles.  Drosophila mutants of the zinc finger transcription factor 
escargot (esg) display ectopic entry into the endocycle in normally diploid larval histoblasts 
(Hayashi et al., 1993).  Esg acts to maintain the activity of Cdk1, which when inactivated can 
trigger endoreplication in normally diploid cells (Hayashi, 1996; Weigmann et al., 1997).  
Similarly, mSna, a murine homologue of Esg, acts to repress the mitotic to endocycle 
transition of trophoblast giant cells (Nakayama et al., 1998). In addition, constitutive ectopic 
expression of Escargot inhibits megakaryocyte endomitosis (Ballester et al., 2001).  The 
basic helix-loop-helix (bHLH) transcription factor superfamily member, Hand1, promotes 
trophoblast giant cell differentiation and endoreplication, but the mechanism by which Hand1 
(e.g. via transcriptional targets) acts is not known (Martindill and Riley, 2008).    
Endocycle specific regulation 
We have been emphasizing similarities in replication control between mitotic cycles 
and endocycles.  As more and more is learned about endocycle regulation, these similarities 
of molecular mechanism may seem obvious in retrospect, as completely new mechanisms for 
fundamental cell biological processes like DNA replication typically do not arise during 
evolution.  However, recent data has provided hints that there may indeed be endocycle-
specific mechanisms, or at least modifications of core regulation that support specific aspects 
of the biology of endocycling cells. 
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Endocycle modulation of pre-RC assembly   
Endoreplicating cells in plants and animals control and respond to the expression of 
pre-RC components differently than in proliferating cells.  Arabidopsis contains two ORC1 
genes which are targets of E2F and that show peaks of expression as cells enter S phase.  One 
of these two ORC1 genes is preferentially expressed in endocycling tissues (Diaz-Trivino et 
al., 2005).  Similarly, human CDC6 contains an endocycle-specific cis regulatory element 
that binds to Esg (Vilaboa et al., 2004).  Pre-RC components are more stable in 
endoreduplicating plant cells and megakaryocytes (Bermejo et al., 2002; Castellano et al., 
2001).   
A recent report raised the possibility that regulation of pre-RC assembly may be 
different in endocycling cells (Park and Asano, 2008).  Drosophila orc1 mutants survive 
through larval development and the highly polyploid salivary glands of these mutants were 
indistinguishable from wild type.  As Orc1 is a critical component of pre-RCs and is essential 
for DNA replication in other contexts (Bell and Dutta, 2002), one possibility is that 
maternally-derived Orc1 protein is sufficient to support DNA replication during larval 
growth, as suggested by genetic studies of other Drosophila Orc subunits (Pflumm and 
Botchan, 2001; Pinto et al., 1999). Interestingly, Park and Asano (2008) could not detect 
Orc1 protein in orc1 mutant salivary glands and concluded that Drosophila Orc1 is 
dispensable for endoreplication. This is particularly surprising because Orc1 is required for 
cell proliferation and for gene amplification in follicle cells (Park and Asano, 2008).  
Moreover, other components of the pre-RC such as Cdt1 are required for endoreplication 
(Park and Asano, 2008). Because Drosophila Orc1 is degraded at mitosis by the APC/C 
(Araki et al., 2003; Araki et al., 2005), presumably including the last mitosis before the onset 
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of endocycles, there should be no Orc1 present when salivary gland cells transition to the 
endocycle during embryogenesis.  However, embryonic salivary gland cells enter the first 
endoreplication S phase from G2 (Smith and Orr-Weaver, 1991), suggesting that a small 
amount of Orc1 synthesized during interphase from maternal transcript could be present in 
orc1 mutant salivary gland cells.  However, this interpretation demands that an amount of 
Orc1 below detection by molecular and microscopic methods is sufficient to support genome 
duplication to the level of 1000C over the course of larval development.  A discussion of 
possible Orc-independent endoreplication can be found in (Asano, 2009). 
Endocycle modulation of the DNA damage response 
In endocycling cells, S phase is often terminated before the entire genome has been 
duplicated (Smith and Orr-Weaver, 1991).  In Drosophila polyploid cells, pericentric 
heterochromatin is often under-replicated (Leach et al., 2000; Lilly and Spradling, 1996).  
After repeated endocycles this results in many stalled replication forks that trigger a DNA 
damage response.  This damage occurs in or near the under-replicated heterochromatin where 
replication forks presumably stall (Hong et al., 2007; Mehrotra et al., 2008).  Mitotic cells 
respond to damage resulting from stalled replication forks either by arresting the cell cycle or 
by inducing apoptosis, but endocycling cells do neither.  How does the cell differentiate 
between the type of cycle utilized and the level of sensitivity to unreplicated, or damaged, 
DNA?  Mehrotra et al. (2008) probed this question by inducing re-replication-mediated DNA 
damage with over-expression of Cdt1.  In diploid cells, this treatment triggers apoptosis via 
p53-dependent and -independent pathways.  However, despite the accumulation of DNA 
damage in endocycling cells in response to Cdt1 over-expression, there was no evidence of 
induction of apoptosis.  While endocycling cells can still respond to pro-apoptotic genes and 
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enter apoptosis, they have a muted response to p53 activation and express pro-apoptotic 
genes at a lower level than cycling diploid cells (Mehrotra et al., 2008). Similarly, DNA 
damage induced by chromatin assembly factor-1 (CAF-1) depletion does not adversely affect 
endocycle progression (Klapholz et al., 2009). Thus, polyploid cells have evolved a 
mechanism to buffer against the DNA damage that accumulates during normal endocycle 
progression. 
A similar situation exists in mammals.  In the process of trophoblast stem cells 
differentiating into endocycling trophoblast giant cells, p57 expression in response to FGF4 
deprivation initiates the transition to endocycles by inhibiting Cdk1, which is required to 
enter mitosis, while the CKI p21 suppresses expression of the checkpoint protein kinase 
Chk1 (Ullah et al., 2008).  p21 is not required for endocycle initiation, but instead is needed 
to suppress the DNA damage response.  Thus, this combination of regulation induces the 
transition into endocycles while preventing the normal cell cycle checkpoint machinery from 
detecting endoreplication as detrimental DNA damage.  
SUMMARY  
Recent research has provided new insight into the mechanisms of endoreplication and 
the function of polyploidization.  Endoreplication is generally controlled by the same cell 
cycle regulators that drive the cell division cycle, particularly those that control the G1-S 
transition and subsequent DNA synthesis.  Importantly, endoreplication is highly conserved 
in evolution and is employed as a form of growth by multiple cell types that perform 
specialized functions during the development of many plant and animal species.  In each of 
these species, the magnitude of polyploidization varies from one cell type to another, but 
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little is known about how this is achieved or what function it might serve.  More recently, 
there is increasing appreciation for how endoreplication and polyploidy contribute to stress 
response and pathogenesis, but much remains to be learned in this regard.  Our increasing 
knowledge of, and ability to manipulate, cell cycle progression should provide the tools to 
address these interesting questions.   
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CHAPTER V 
 
DISCUSSION AND FUTURE DIRECTIONS 
 
 
By utilizing established tools of Drosophila genetics in combination with known 
functional alleles of E2f1, we were able to address the question of the biological requirement 
of E2f1 S phase-coupled destruction. In this thesis, we started with the question of how E2F1 
stablization can be measured both S2 cells as well as in proliferating imaginal wing discs 
(Chapter II). By utilizing this assay as well as generating several Drosophila alleles that 
disrupted known functions of E2f1 protein, we found that the stabilization of E2F1 causes 
apoptosis in rapidly proliferating tissues, yet this apoptosis is not due to activity of E2f1 as a 
transcription factor.  Instead, it was only when E2f1 lacked a functional Rb binding domain 
that stabilization of this protein failed to induce apoptosis.  Following this observation, we 
sought to understand the mechanism.  We proposed a “sensor” model, where stabilized E2f1 
may titrate Rb away from a repressive complex found distally upstream of the promoter of a 
pro-apoptotic gene called hid.  We observed that hid transcripts increased following the 
expression of E2f1 alleles with intact Rb-binding domains, and could reduce apoptosis with 
reduction of hid gene dosage.  We demonstrated that this sensor is present in order to 
maintain tissue homeostasis in rapidly proliferating tissues, such as imaginal discs, and that 
stabilized E2f1 may cause neoplastic growth if apoptosis is blocked (Chapter III). In 
addition, we overviewed the current literature surrounding the mechanism and function of 
atypical cell cycles on normal development and their possible contributions towards disease 
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(Chapter IV). Overall, this dissertation focuses on biological mechanisms required for 
maintaining genomic integrity, which is achieved both through careful regulation of the cell 
cycle, and the distinct “choice” of atypical cell cycles as required for normal development.  
 
Regulation of Onset of E2f1 S Phase Coupled Destruction 
During Drosophila embryogenesis, prior to the onset of zygotic transcription, E2f1 is 
stable during S phase with no severe consequences (Shibutani et al., 2007).  However, recent 
evidence suggests that all the required players for the CRL4Cdt2 ubiquitin mediated 
proteolysis are maternally contributed and active (C. Swanson, pers. comm).  The rapid 
nature of the early syncitial cycles (S-M1-13) may require E2f1 to be protected from 
destruction, as all E2f1 protein is maternally supplied at this point and zygotic transcription 
has not initiated.  E2f1 mutant embryos show impaired DNA replication when the maternal 
supply of E2f1 is depleted (Duronio et al., 1995).   
However, the developmental signal regulating the onset of E2f1 destruction is 
currently unknown. The signal may be the downregulation of a maternally loaded protein or 
RNA that protects E2f1 from destruction, the induction of a zygotic gene that is required for 
the destruction of E2f1, or a post-translational modification which could protect E2f1 from 
degredation.  It is clear that this stabilization of E2f1 in the early cycles does not activate 
apoptosis, raising interesting questions about what developmental context allows the culling 
of cells with inappropriate E2f1 levels, and where it is best to keep those cells around.  One 
hypothesis raised is that once cells differentiate and obtain tight regulation by external 
signals, cells with inappropriately high levels of E2f1 during S phase may have to be 
eliminated in order to prevent overproliferation and/or DNA re-replication caused by 
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elevated E2f1 activity.  Another is that rapidly proliferating tissues have a lower threshold for 
allowing cells with inappropriate E2f1 levels to persist in the population, as there are robust 
compensatory mechanisms to replace cells that apoptosis, and the rapid cell proliferation 
could allow a small population of hyper-proliferative cells to have serious consequences on 
the development and homeostasis of the tissue.   
 
E2f1 Stabilization induced DNA Damage 
Similarly intriguing, other CRL4Cdt2 targets have been shown to be destroyed 
following UV damage (Hu et al., 2004; Jorgensen et al., 2011; Nishitani et al., 2008; Soria 
and Gottifredi, 2010).  This seems logical, as many of the targets are required for the 
progression of the cell cycle and their destruction may act as an arrest mechanism to allow 
sufficient time for DNA repair (Barkley et al., 2007).  However, it has been demonstrated 
that  mammalian E2F1 is not destroyed following UV damage (Hofferer et al., 1999).  
Conversely, E2F1 has been implicated in DNA damage repair as E2FI/DNA interactions 
increased as well as up-regulation of specific target gene expression, such as ribonucleotide 
reductase (Filatov et al., 1996). Yet, our results demonstrate that E2f1 is not destroyed 
following UV damage (Fig 5.1).    
Figure 5.1:  E2f1 is stabilized following UV radiation, while Cdt1 is destroyed.  A) Western blot measuring 
levels of E2f1 and Cdt1 in S2 cells following 200uJ/cm2 UV radiation over 24 hours.  E2f1 levels remain 
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constant, while Cdt1 is immediately destroyed and reaccumulates hours later. beta-tubulin as loading control.  
B) Western blot comparing E2f1 and Cdt1 levels with or without UV radiation over 90 minute time course.  
 
These preliminary results suggest that there may be a mechanism where Drosophila 
E2f1 can avoid ubiquitin-mediated proteolysis via the CRL4Cdt2 mechanism in order to 
participate in DNA damage repair.  Perhaps E2f1 is modified, not destroyed, so that cell 
cycle re-entry can occur rapidly after DNA damage repair, instead of necessitating the new 
synthesis of E2f1 protein.  E2f1 consistently appears as a doublet, suggesting there maybe a 
post-translational modification which could be supporting this stabilization.  While 
preliminary results suggest it is not phosphorylation, as phosphatase treatment does not result 
in band shifts, we have utilized SUMOsp 2.0 software to identify potential sumolaytion cites 
in E2f1.  Sumolyation is promising, as another CRL4Cdt2 target, Polη, is sumolayted by GEI-
17 in c.elegans in order to prevent Cdt2 binding while Polη acts as a translesion synthetase 
following DNA damage (Kim and Michael, 2008).  Only after Polη has bypassed the lesion 
and the sumolatyion has been removed, can Cdt2 target this protein for destruction, to 
prevent its’ activity during normal DNA replication.   It will be intriguing to investigate 
whether the mechanism which protects E2f1 from degradation in the early embryo is the 
same mechanism at play after DNA damage and could potentially uncover more details of 
the CRL4Cdt2 dependent mechanism of proteolysis and general cell cycle regulation.   
 
The Mechanism of hid Expression  
Our data shown here suggest that hid gene expression is increased following the 
stabilization of E2f1 in S phase due to de-repression of an Rbf1 containing complex upstream 
of the promoter.  However, the same publication that presented the presence of this 
repressive complex, and that hid expression could be induced by removing Rbf1, did not 
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implicate E2f1 as the transcription factor responsible for hid expression (Moon et al., 2008).  
Therefore, while it is previously known that E2f1 may drive expression of known pro-
apoptotic genes directly, especially reaper, we propose this stabilized E2f1 sensor mechanism 
is independent of E2f1 transcriptional activity.  This hypothesis is supported by the 
expression of a transcriptionally inert E2f1 molecule resulting in a robust apoptotic response 
(Fig. 3.2).  It is further supported by genetic evidence that reducing hid gene dose results in 
less cell death (Fig 3.5).  This raises interesting questions about the specific mechanism at 
hand.  First, how is this apoptotic mechanism repressed during normal cell cycle 
progression?  Our model predicts that stable E2f1 is able to titrate Rbf1 away from a 
repressive complex which also contains endogenous E2f1.  But, as mentioned in the 
introduction, during the G1-S transition, CyclinE/CDK2 levels accumulate in order to hyper-
phosphorylate Rbf1 and prevent its’ binding to E2f1 (Frolov and Dyson, 2004).  How does 
Rbf1 at this repressive locus bypass this phosphorylation that could potentially be so 
deletrious (such as the cell would not want to activate hid every S phase)?  Secondly, how 
does the repressive complex work biologically?  The E2f1 binding sites to which Rbf1 
protein was detected via ChIP are -1.2kb upstream of the hid promoter (Moon et al., 2008).  
And, as mentioned above, E2f1 is not the transcription factor responsible for hid gene 
expression.  It will be interesting to uncover which factor is responsible for initiating hid 
expression and the regulation surrounding its activation. 
It is intriguing to consider this repressive complex functioning via interactions with 
the known histone modifying partners known to bind Rb (Funayama and Ishikawa, 2007).  It 
was previously reported that Rbf1 plays a critical role in condensing chromatin during 
mitosis (Longworth et al., 2008). However, recent observations have suggested that this 
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condensation role is not exclusive to mitosis.  Instead, many genes are reguated at the 
transcriptional level based on chromatin environment regulated by Rbf1 (Longworth et al., 
2012).  Also, the E2F/Rb containing complex, dREAM/MMB, has been implicated in 
regulation of gene expression via chromatin modifications, especially in the context of 
differentiation (Lee et al., 2012).   
It will be interesting to understand the specificity of the Rbf1/E2f1 interaction at the 
repressive complex upstream of hid.  Our results demonstrate that apoptosis cannot be 
induced simply by titrating Rbf1 away with an E2f1 protein with only the Rb-binding domain 
intact (Figure 3.6).  Instead, it seems there is some uncharacterized functional domain within 
the first 336 amino acids that is critical for the cells ability to sense the inappropriate stability 
of E2f1 and induce cell death.  It will be interesting to investigate both the potential 
functional domains of E2f1 and the chromatin environment around the hid locus during 
normal cell cycle progression and following the stabilization of E2f1.  
 
The Global Consequences of E2f1 Mis-regulation 
 The hypothesis that the repressive complex upstream of hid depends on chromatin 
modifications brings up interesting questions about the specificity of hid activation after E2f1 
stabilization.  It is interesting to consider that the stabilzation of E2f1 could titrate Rbf1 away 
from multiple repressive loci.  In order to investigate this possibility, we are currently 
measuring global gene expression changes using high-throughput RNA sequencing.  We 
have collected RNA from imaginal discs expressing GFP alone, GFP-E2f1WT , GFP-
E2f1Stable,  and E2f1Stable/DBD.  We generated cDNA with the appropriate adaptors and bar 
codes following the Illumina protocol.  It will be interesting to compare changes in both E2f1 
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target gene expression following stabilization as well as the changes that occur after 
expression of the transcriptionally inert E2f1 transgene (Figure 5.2).  By making pair-wise 
comparisons, we may be able to identify genes whose expression increases after E2f1 
stabilization, but is not dependent on E2f1 transcription.  The expression changes of the gene 
hid will act as our positive control.  This experiment could potentially uncover multiple 
genes responsible for the “sensing” of inappropriate E2f1 levels in order to maintain tissue 
homeostasis.  
 
Figure 5.2: Schematic of Gene Expression Profiles During Cell Cycle  
 
Concluding Remarks    
 The work presented in this thesis has advanced our understanding about E2f1 
regulation in the context of development and tissue homeostasis. We showed evidence that 
the S phase specific stabilization of E2f1 induces apoptosis independently of its’ 
transcriptional activitiy and uncovered a potential mechanism to carefully sense E2f1 levels 
in rapidly proliferative tissues in order to prevent potential neoplastic growth. By expressing 
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E2f1 transgenes with mutations in known functional domains, we were able to understand 
this mechanism requires an intact E2f1/Rbf1 interaction.  We therefore proposed a 
mechanism where stabilized E2f1 could titrate Rbf1 away from a repressive complex 
upstream of a pro-apoptotic gene called hid. We demonstrated that this mechanism can 
quickly sense inappropriate stabilization of E2f1 protein and induce a robust apoptotic 
response.  If apoptosis is not completed, stabilized E2f1 causes severe tissue overgrowth in 
imaginal wing discs.  This supports the hypothesis that cells maintain a mechanism to 
quickly sense E2f1 levels and respond with programmed cell death before that cell has the 
potential to precociously re-enter the cell cycle or undergo re-replication stress and endanger 
the overall homeostasis of the tissue.  
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